0000704415 --12-31 FY false 3200000 P3Y P3Y 1 1 P2Y 2021-12-31 2025-12-31 2021-12-31 2036-12-31 1 1 P3Y P6Y2M12D P6Y8M12D P5Y2M12D P3Y tvty:CurrentLeaseLiabilities tvty:CurrentLeaseLiabilities tvty:NoncurrentLeaseLiabilities tvty:NoncurrentLeaseLiabilities P2Y7M6D P1Y7M6D 0000704415 2020-01-01 2020-12-31 iso4217:USD 0000704415 2020-06-30 xbrli:shares 0000704415 2021-02-19 0000704415 2020-12-31 0000704415 2019-12-31 iso4217:USD xbrli:shares 0000704415 2019-01-01 2019-12-31 0000704415 2018-01-01 2018-12-31 0000704415 us-gaap:CommonStockMember 2017-12-31 0000704415 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0000704415 us-gaap:RetainedEarningsMember 2017-12-31 0000704415 us-gaap:TreasuryStockMember 2017-12-31 0000704415 2017-12-31 0000704415 us-gaap:RetainedEarningsMember 2018-01-01 2018-12-31 0000704415 us-gaap:CommonStockMember 2018-01-01 2018-12-31 0000704415 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-12-31 0000704415 us-gaap:CommonStockMember 2018-12-31 0000704415 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000704415 us-gaap:RetainedEarningsMember 2018-12-31 0000704415 us-gaap:TreasuryStockMember 2018-12-31 0000704415 2018-12-31 0000704415 us-gaap:RetainedEarningsMember 2019-01-01 2019-12-31 0000704415 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-12-31 0000704415 us-gaap:CommonStockMember 2019-01-01 2019-12-31 0000704415 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-12-31 0000704415 us-gaap:CommonStockMember 2019-12-31 0000704415 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000704415 us-gaap:RetainedEarningsMember 2019-12-31 0000704415 us-gaap:TreasuryStockMember 2019-12-31 0000704415 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000704415 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0000704415 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0000704415 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0000704415 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0000704415 us-gaap:CommonStockMember 2020-12-31 0000704415 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000704415 us-gaap:RetainedEarningsMember 2020-12-31 0000704415 us-gaap:TreasuryStockMember 2020-12-31 0000704415 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000704415 tvty:NutrisystemMember 2020-01-01 2020-12-31 tvty:Program 0000704415 2018-01-01 2018-01-01 0000704415 tvty:ComputerSoftwareAndHardwareMember srt:MinimumMember 2020-01-01 2020-12-31 0000704415 tvty:ComputerSoftwareAndHardwareMember srt:MaximumMember 2020-01-01 2020-12-31 0000704415 us-gaap:FurnitureAndFixturesMember srt:MinimumMember 2020-01-01 2020-12-31 0000704415 us-gaap:FurnitureAndFixturesMember srt:MaximumMember 2020-01-01 2020-12-31 0000704415 us-gaap:EquipmentMember srt:MinimumMember 2020-01-01 2020-12-31 0000704415 us-gaap:EquipmentMember srt:MaximumMember 2020-01-01 2020-12-31 0000704415 us-gaap:LeaseholdImprovementsMember srt:MinimumMember 2020-01-01 2020-12-31 0000704415 us-gaap:LeaseholdImprovementsMember srt:MaximumMember 2020-01-01 2020-12-31 0000704415 us-gaap:OtherAssetsMember 2020-12-31 0000704415 srt:MinimumMember 2020-01-01 2020-12-31 0000704415 srt:MaximumMember 2020-01-01 2020-12-31 0000704415 srt:MinimumMember 2019-01-01 2019-12-31 0000704415 srt:MaximumMember 2019-01-01 2019-12-31 0000704415 us-gaap:HealthCareMember 2019-12-31 0000704415 us-gaap:HealthCareMember 2018-12-31 tvty:Segment 0000704415 tvty:NetworkLocationVisitsMember 2020-12-31 0000704415 tvty:NetworkLocationVisitsMember 2019-12-31 0000704415 us-gaap:SegmentContinuingOperationsMember 2020-01-01 2020-12-31 0000704415 us-gaap:SegmentContinuingOperationsMember 2019-01-01 2019-12-31 0000704415 us-gaap:SegmentContinuingOperationsMember 2018-01-01 2018-12-31 0000704415 us-gaap:SegmentContinuingOperationsMember 2020-12-31 0000704415 us-gaap:SegmentContinuingOperationsMember 2019-12-31 0000704415 tvty:NutrisystemIncorporationMember 2020-12-09 0000704415 tvty:NutrisystemIncorporationMember us-gaap:OtherCurrentAssetsMember 2020-12-31 0000704415 tvty:NutrisystemIncorporationMember 2020-12-31 0000704415 tvty:NutrisystemIncorporationMember 2020-01-01 2020-12-31 0000704415 tvty:NutrisystemIncorporationMember 2019-12-31 0000704415 tvty:NutrisystemIncorporationMember 2019-01-01 2019-12-31 0000704415 tvty:NutrisystemIncorporationMember us-gaap:LongTermDebtMember tvty:CreditAgreementMember 2020-12-09 2020-12-09 0000704415 tvty:NutrisystemIncorporationMember us-gaap:LongTermDebtMember 2019-03-08 2020-12-08 tvty:Obligation xbrli:pure 0000704415 tvty:SilverSneakersMember us-gaap:SegmentContinuingOperationsMember 2020-01-01 2020-12-31 0000704415 tvty:SilverSneakersMember us-gaap:SegmentContinuingOperationsMember 2019-01-01 2019-12-31 0000704415 tvty:SilverSneakersMember us-gaap:SegmentContinuingOperationsMember 2018-01-01 2018-12-31 0000704415 tvty:PrimeFitnessMember us-gaap:SegmentContinuingOperationsMember 2020-01-01 2020-12-31 0000704415 tvty:PrimeFitnessMember us-gaap:SegmentContinuingOperationsMember 2019-01-01 2019-12-31 0000704415 tvty:PrimeFitnessMember us-gaap:SegmentContinuingOperationsMember 2018-01-01 2018-12-31 0000704415 tvty:WholeHealthLivingMember us-gaap:SegmentContinuingOperationsMember 2020-01-01 2020-12-31 0000704415 tvty:WholeHealthLivingMember us-gaap:SegmentContinuingOperationsMember 2019-01-01 2019-12-31 0000704415 tvty:WholeHealthLivingMember us-gaap:SegmentContinuingOperationsMember 2018-01-01 2018-12-31 0000704415 us-gaap:ProductAndServiceOtherMember us-gaap:SegmentContinuingOperationsMember 2020-01-01 2020-12-31 0000704415 us-gaap:ProductAndServiceOtherMember us-gaap:SegmentContinuingOperationsMember 2019-01-01 2019-12-31 0000704415 us-gaap:ProductAndServiceOtherMember us-gaap:SegmentContinuingOperationsMember 2018-01-01 2018-12-31 0000704415 us-gaap:ProductAndServiceOtherMember 2020-01-01 2020-12-31 0000704415 tvty:WellBeingProgramMember 2020-01-01 2020-12-31 0000704415 us-gaap:LeaseholdImprovementsMember 2020-12-31 0000704415 us-gaap:LeaseholdImprovementsMember 2019-12-31 0000704415 tvty:ComputerEquipmentAndRelatedSoftwareMember 2020-12-31 0000704415 tvty:ComputerEquipmentAndRelatedSoftwareMember 2019-12-31 0000704415 tvty:FurnitureAndOfficeEquipmentMember 2020-12-31 0000704415 tvty:FurnitureAndOfficeEquipmentMember 2019-12-31 0000704415 tvty:CapitalProjectsInProcessMember 2020-12-31 0000704415 tvty:CapitalProjectsInProcessMember 2019-12-31 0000704415 tvty:AcquiredTechnologyMember 2020-12-31 0000704415 us-gaap:DistributionRightsMember 2020-12-31 0000704415 tvty:AcquiredTechnologyMember 2019-12-31 0000704415 us-gaap:DistributionRightsMember 2019-12-31 0000704415 us-gaap:TradeNamesMember 2020-12-31 0000704415 us-gaap:TradeNamesMember 2019-12-31 tvty:Type 0000704415 us-gaap:RestrictedStockMember 2020-12-31 0000704415 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-12-31 0000704415 srt:MinimumMember us-gaap:EmployeeStockOptionMember 2020-01-01 2020-12-31 0000704415 us-gaap:EmployeeStockOptionMember srt:MaximumMember 2020-01-01 2020-12-31 0000704415 srt:MinimumMember us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-12-31 0000704415 us-gaap:RestrictedStockUnitsRSUMember srt:MaximumMember 2020-01-01 2020-12-31 0000704415 srt:MinimumMember us-gaap:PerformanceSharesMember 2020-01-01 2020-12-31 0000704415 srt:MaximumMember us-gaap:PerformanceSharesMember 2020-01-01 2020-12-31 0000704415 tvty:MarketStockUnitsMember 2020-01-01 2020-12-31 0000704415 tvty:TimeVestingRestrictedStockAwardsMember tvty:EmployeesMember tvty:NutrisystemMember 2019-03-01 2019-03-31 0000704415 tvty:TimeVestingRestrictedStockUnitsMember tvty:EmployeesMember tvty:NutrisystemMember 2019-03-01 2019-03-31 0000704415 tvty:ReplacementAwardsMember tvty:NutrisystemMember 2020-01-01 2020-12-31 0000704415 tvty:ReplacementAwardsMember tvty:NutrisystemMember 2019-01-01 2019-12-31 0000704415 us-gaap:CostOfSalesMember 2020-01-01 2020-12-31 0000704415 us-gaap:CostOfSalesMember 2019-01-01 2019-12-31 0000704415 us-gaap:CostOfSalesMember 2018-01-01 2018-12-31 0000704415 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-12-31 0000704415 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-12-31 0000704415 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-01-01 2018-12-31 0000704415 us-gaap:RestructuringChargesMember 2020-01-01 2020-12-31 0000704415 us-gaap:SegmentDiscontinuedOperationsMember 2020-01-01 2020-12-31 0000704415 us-gaap:SegmentDiscontinuedOperationsMember 2019-01-01 2019-12-31 0000704415 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-12-31 0000704415 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-12-31 0000704415 us-gaap:RestrictedStockUnitsRSUMember 2018-01-01 2018-12-31 0000704415 us-gaap:PerformanceSharesMember 2020-01-01 2020-12-31 0000704415 us-gaap:PerformanceSharesMember 2019-01-01 2019-12-31 0000704415 tvty:MarketStockUnitsMember 2019-01-01 2019-12-31 0000704415 tvty:MarketStockUnitsMember 2018-01-01 2018-12-31 0000704415 us-gaap:PerformanceSharesMember 2018-01-01 2018-12-31 0000704415 2017-01-01 2017-12-31 0000704415 us-gaap:RestrictedStockMember 2019-12-31 0000704415 us-gaap:RestrictedStockMember 2020-01-01 2020-12-31 0000704415 us-gaap:RestrictedStockUnitsRSUMember 2019-12-31 0000704415 us-gaap:RestrictedStockUnitsRSUMember 2020-12-31 0000704415 us-gaap:PerformanceSharesMember 2019-12-31 0000704415 us-gaap:PerformanceSharesMember 2020-12-31 0000704415 tvty:MarketStockUnitsMember 2020-12-31 0000704415 us-gaap:StateAndLocalJurisdictionMember 2019-01-01 2019-12-31 0000704415 us-gaap:StateAndLocalJurisdictionMember 2020-01-01 2020-12-31 0000704415 us-gaap:ForeignCountryMember 2020-12-31 0000704415 us-gaap:StateAndLocalJurisdictionMember 2020-12-31 0000704415 tvty:TPHSAndNutrisystemMember 2020-12-31 0000704415 tvty:IndefiniteCarryforwardMember 2020-12-31 0000704415 us-gaap:CapitalLossCarryforwardMember 2020-12-31 0000704415 us-gaap:CapitalLossCarryforwardMember us-gaap:EarliestTaxYearMember 2020-01-01 2020-12-31 0000704415 us-gaap:CapitalLossCarryforwardMember us-gaap:LatestTaxYearMember 2020-01-01 2020-12-31 0000704415 us-gaap:StateAndLocalJurisdictionMember us-gaap:EarliestTaxYearMember 2020-01-01 2020-12-31 0000704415 us-gaap:StateAndLocalJurisdictionMember us-gaap:LatestTaxYearMember 2020-01-01 2020-12-31 0000704415 us-gaap:EarliestTaxYearMember 2020-01-01 2020-12-31 tvty:Agreement 0000704415 us-gaap:AccountingStandardsUpdate201602Member srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember 2019-01-01 2019-12-31 0000704415 tvty:TermLoanFacilityAMember 2020-12-31 0000704415 tvty:TermLoanFacilityAMember 2019-12-31 0000704415 tvty:TermLoanFacilityBMember 2020-12-31 0000704415 tvty:TermLoanFacilityBMember 2019-12-31 0000704415 us-gaap:RevolvingCreditFacilityMember 2019-12-31 0000704415 tvty:CreditAgreementMember 2020-01-01 2020-12-31 0000704415 tvty:CreditAgreementMember us-gaap:RevolvingCreditFacilityMember 2019-03-08 0000704415 tvty:CreditAgreementMember tvty:SwinglineSubFacilityMember 2019-03-08 0000704415 tvty:CreditAgreementMember us-gaap:LetterOfCreditMember 2019-03-08 0000704415 tvty:CreditAgreementMember tvty:TermLoanFacilityAMember 2019-03-08 0000704415 tvty:CreditAgreementMember tvty:TermLoanFacilityBMember 2019-03-08 0000704415 tvty:CreditAgreementMember tvty:UncommittedIncrementalAccordionFacilityMember srt:MinimumMember 2019-03-08 0000704415 tvty:CreditAgreementMember tvty:UncommittedIncrementalAccordionFacilityMember srt:MinimumMember 2019-03-08 2019-03-08 0000704415 tvty:CreditAgreementMember 2020-12-31 0000704415 us-gaap:RevolvingCreditFacilityMember 2020-12-31 0000704415 tvty:CreditAgreementMember us-gaap:LondonInterbankOfferedRateLIBORMember srt:MinimumMember 2019-03-08 2019-03-08 0000704415 tvty:CreditAgreementMember tvty:FederalFundsRateMember 2019-03-08 2019-03-08 0000704415 tvty:CreditAgreementMember tvty:OneMonthLondonInterbankOfferedRateLIBORMember 2019-03-08 2019-03-08 0000704415 tvty:CreditAgreementMember us-gaap:LondonInterbankOfferedRateLIBORMember tvty:TermLoanFacilityAMember 2019-03-08 2019-03-08 0000704415 tvty:CreditAgreementMember us-gaap:LondonInterbankOfferedRateLIBORMember tvty:TermLoanFacilityBMember 2019-03-08 2019-03-08 0000704415 tvty:CreditAgreementMember us-gaap:LondonInterbankOfferedRateLIBORMember us-gaap:RevolvingCreditFacilityMember srt:MinimumMember 2019-03-08 2019-03-08 0000704415 tvty:CreditAgreementMember us-gaap:LondonInterbankOfferedRateLIBORMember us-gaap:RevolvingCreditFacilityMember srt:MaximumMember 2019-03-08 2019-03-08 0000704415 tvty:CreditAgreementMember us-gaap:BaseRateMember tvty:TermLoanFacilityAMember 2019-03-08 2019-03-08 0000704415 tvty:CreditAgreementMember us-gaap:BaseRateMember tvty:TermLoanFacilityBMember 2019-03-08 2019-03-08 0000704415 tvty:CreditAgreementMember us-gaap:BaseRateMember us-gaap:RevolvingCreditFacilityMember srt:MinimumMember 2019-03-08 2019-03-08 0000704415 tvty:CreditAgreementMember us-gaap:BaseRateMember us-gaap:RevolvingCreditFacilityMember srt:MaximumMember 2019-03-08 2019-03-08 0000704415 tvty:CreditAgreementMember tvty:TermLoanFacilityAMember 2019-03-08 2019-03-08 0000704415 tvty:CreditAgreementMember tvty:TermLoanFacilityBMember 2019-03-08 2019-03-08 0000704415 tvty:CreditAgreementMember tvty:TermLoansMember 2019-03-09 2020-12-31 0000704415 tvty:CreditAgreementMember tvty:NutrisystemIncorporationMember 2020-12-01 2020-12-31 0000704415 tvty:CreditAgreementMember tvty:TermLoanFacilityAMember 2020-01-01 2020-12-31 0000704415 tvty:CreditAgreementMember tvty:TermLoanFacilityBMember 2020-01-01 2020-12-31 0000704415 tvty:CreditAgreementMember tvty:TermLoansMember 2019-03-09 2019-12-31 0000704415 tvty:CreditAgreementMember tvty:SwinglineSubFacilityMember 2020-01-01 2020-12-31 0000704415 tvty:CreditAgreementMember us-gaap:RevolvingCreditFacilityMember 2020-01-01 2020-12-31 0000704415 tvty:InterestRateSwapAgreementMember 2019-05-31 0000704415 tvty:InterestRateSwapAgreementMember 2019-05-01 2019-05-31 0000704415 tvty:InterestRateSwapAgreementMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-05-31 0000704415 tvty:EightInterestRateSwapsMember 2020-12-31 0000704415 tvty:EightInterestRateSwapsMember us-gaap:HedgeFundsEquityMember 2020-12-31 0000704415 tvty:EightInterestRateSwapsMember us-gaap:HedgeFundsEquityMember 2020-10-01 2020-12-31 0000704415 tvty:PrepaymentsConditionOneMember tvty:CreditAgreementMember 2020-01-01 2020-12-31 0000704415 tvty:PrepaymentsConditionTwoMember tvty:CreditAgreementMember 2020-01-01 2020-12-31 0000704415 tvty:PrepaymentsConditionThreeMember tvty:CreditAgreementMember 2020-01-01 2020-12-31 0000704415 tvty:PrepaymentsConditionFourMember tvty:CreditAgreementMember 2020-01-01 2020-12-31 0000704415 tvty:CreditAgreementMember tvty:TermLoanFacilityAMember 2019-12-31 0000704415 tvty:CreditAgreementMember tvty:TermLoanFacilityAMember 2020-12-31 0000704415 tvty:CreditAgreementMember tvty:TermLoanFacilityBMember 2019-12-31 0000704415 tvty:CreditAgreementMember tvty:TermLoanFacilityBMember 2020-12-31 0000704415 tvty:CreditAgreementMember srt:MinimumMember 2019-03-08 2019-03-08 0000704415 tvty:CreditAgreementMember srt:MaximumMember 2019-03-08 2019-03-08 0000704415 tvty:CreditAgreementMember 2019-01-01 2019-12-31 0000704415 2017-11-06 tvty:Lawsuit 0000704415 2017-11-06 2017-11-06 0000704415 tvty:NutrisystemIncorporationMember 2020-01-01 2020-03-31 0000704415 us-gaap:SegmentContinuingOperationsMember 2020-01-01 2020-03-31 0000704415 us-gaap:TradeNamesMember us-gaap:SegmentContinuingOperationsMember tvty:SilverSneakersMember 2020-01-01 2020-03-31 0000704415 tvty:NutritionBusinessUnitMember 2020-10-18 2020-10-18 0000704415 us-gaap:SegmentDiscontinuedOperationsMember tvty:NutritionMember 2020-07-01 2020-09-30 0000704415 us-gaap:SegmentDiscontinuedOperationsMember tvty:NutritionMember 2020-10-01 2020-12-31 0000704415 tvty:NutrisystemIncorporationMember srt:ScenarioForecastMember 2021-01-01 2021-12-31 0000704415 us-gaap:InterestRateSwapMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0000704415 us-gaap:InterestRateSwapMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000704415 us-gaap:InterestRateSwapMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:NondesignatedMember 2020-12-31 0000704415 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2020-12-31 0000704415 tvty:TermLoansMember 2020-12-31 0000704415 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-05-31 0000704415 us-gaap:InterestRateSwapMember 2020-01-01 2020-12-31 0000704415 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember 2020-10-01 2020-12-31 0000704415 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember 2020-10-01 2020-10-31 0000704415 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-05-01 2019-05-31 0000704415 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0000704415 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember 2020-12-31 0000704415 tvty:LongTermLiabilitiesCurrentMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestRateSwapMember 2020-12-31 0000704415 tvty:LongTermLiabilitiesCurrentMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestRateSwapMember 2019-12-31 0000704415 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestRateSwapMember 2020-12-31 0000704415 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestRateSwapMember 2019-12-31 0000704415 us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestRateSwapMember 2019-12-31 0000704415 tvty:LongTermLiabilitiesCurrentMember us-gaap:NondesignatedMember us-gaap:InterestRateSwapMember 2020-12-31 0000704415 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:NondesignatedMember us-gaap:InterestRateSwapMember 2020-12-31 0000704415 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember 2020-01-01 2020-12-31 0000704415 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember 2019-01-01 2019-12-31 0000704415 us-gaap:InterestRateSwapMember us-gaap:InterestExpenseMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember 2020-01-01 2020-12-31 0000704415 us-gaap:InterestRateSwapMember us-gaap:InterestExpenseMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember 2019-01-01 2019-12-31 0000704415 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember 2020-01-01 2020-12-31 0000704415 us-gaap:InterestRateSwapMember us-gaap:InterestExpenseMember us-gaap:NondesignatedMember 2020-01-01 2020-12-31 0000704415 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember 2019-01-01 2019-12-31 0000704415 us-gaap:InterestRateSwapMember tvty:IncomeFromDiscontinuedOperationsMember us-gaap:NondesignatedMember 2020-01-01 2020-12-31 0000704415 us-gaap:InterestRateSwapMember us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:NondesignatedMember 2020-01-01 2020-12-31 0000704415 tvty:RestructuringPlan2019Member us-gaap:SegmentContinuingOperationsMember 2020-01-01 2020-12-31 0000704415 tvty:RestructuringPlan2019Member us-gaap:SegmentContinuingOperationsMember 2019-01-01 2019-12-31 0000704415 tvty:TwoThousandTwentyCOVIDRestructuringPlanMember us-gaap:SegmentContinuingOperationsMember 2020-01-01 2020-12-31 0000704415 tvty:TwoThousandTwentyCOVIDRestructuringPlanMember us-gaap:SegmentContinuingOperationsMember 2020-12-31 0000704415 tvty:TwoThousandTwentyRestructuringPlanMember us-gaap:SegmentContinuingOperationsMember 2020-01-01 2020-12-31 0000704415 tvty:TwoThousandTwentyRestructuringPlanMember us-gaap:SegmentContinuingOperationsMember 2020-12-31 0000704415 tvty:RestructuringPlan2019Member us-gaap:SegmentContinuingOperationsMember 2019-12-31 0000704415 tvty:RestructuringPlan2019Member us-gaap:SegmentContinuingOperationsMember 2020-12-31 0000704415 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-12-31 0000704415 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-12-31 0000704415 tvty:HwayWarrantsRelatedToCashConvertibleNotesMember 2018-01-01 2018-12-31 0000704415 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-12-31 0000704415 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-12-31 0000704415 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-12-31 0000704415 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-12-31 0000704415 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-12-31 0000704415 us-gaap:RestrictedStockUnitsRSUMember 2018-01-01 2018-12-31 0000704415 us-gaap:PerformanceSharesMember 2020-01-01 2020-12-31 0000704415 us-gaap:RestrictedStockMember 2020-01-01 2020-12-31 0000704415 us-gaap:RestrictedStockMember 2019-01-01 2019-12-31 0000704415 us-gaap:InterestRateSwapMember 2019-01-01 2019-12-31 0000704415 us-gaap:InterestRateSwapMember 2019-12-31 0000704415 us-gaap:InterestRateSwapMember 2020-01-01 2020-12-31 0000704415 us-gaap:InterestRateSwapMember 2020-12-31 0000704415 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:InterestRateSwapMember 2020-01-01 2020-12-31 0000704415 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:InterestRateSwapMember 2019-01-01 2019-12-31 0000704415 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0000704415 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-12-31 0000704415 us-gaap:HealthCareMember 2020-01-01 2020-12-31 tvty:Customer 0000704415 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0000704415 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember srt:MinimumMember 2020-01-01 2020-12-31 0000704415 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember tvty:CustomerOneMember 2020-01-01 2020-12-31 0000704415 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember tvty:CustomerTwoMember 2020-01-01 2020-12-31 0000704415 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember tvty:CustomerThreeMember 2020-01-01 2020-12-31 0000704415 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0000704415 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember srt:MinimumMember 2020-01-01 2020-12-31 0000704415 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember tvty:CustomerOneMember 2020-01-01 2020-12-31 0000704415 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember tvty:CustomerTwoMember 2020-01-01 2020-12-31 0000704415 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-12-31 0000704415 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember srt:MinimumMember 2019-01-01 2019-12-31 0000704415 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember tvty:CustomerOneMember 2019-01-01 2019-12-31 0000704415 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember tvty:CustomerTwoMember 2019-01-01 2019-12-31 0000704415 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember tvty:CustomerThreeMember 2019-01-01 2019-12-31 0000704415 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-12-31 0000704415 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember srt:MinimumMember 2019-01-01 2019-12-31 0000704415 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember tvty:CustomerOneMember 2019-01-01 2019-12-31 0000704415 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember tvty:CustomerTwoMember 2019-01-01 2019-12-31 0000704415 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember tvty:CustomerThreeMember 2019-01-01 2019-12-31 0000704415 2020-01-01 2020-03-31 0000704415 2020-04-01 2020-06-30 0000704415 2020-07-01 2020-09-30 0000704415 2020-10-01 2020-12-31 0000704415 2019-01-01 2019-03-31 0000704415 2019-04-01 2019-06-30 0000704415 2019-07-01 2019-09-30 0000704415 2019-10-01 2019-12-31 0000704415 us-gaap:SellingGeneralAndAdministrativeExpensesMember tvty:StrategicProjectCostsMember 2020-10-01 2020-12-31 0000704415 us-gaap:SellingGeneralAndAdministrativeExpensesMember tvty:CEOTransitionCostsMember 2020-10-01 2020-12-31 0000704415 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-10-01 2020-12-31 0000704415 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-12-31

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

FORM 10-K

   Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Fiscal Year Ended December 31, 2020

or

Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Transition Period from _____ to ______

Commission file number 000-19364

 

 

TIVITY HEALTH, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

 

 

62-1117144

(State or other jurisdiction of

 

 

 

(I.R.S. Employer

incorporation or organization)

 

 

 

Identification No.)

 

 

 

 

 

701 Cool Springs Boulevard, Franklin, TN  37067

(Address of principal executive offices) (Zip code)

 

 

 

 

 

(800) 869-5311

(Registrant's telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock - $.001 par value

TVTY

The Nasdaq Stock Market LLC

 

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

 

Yes  

 

No  

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act.

 

Yes 

 

No  

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.

 

Yes  

 

 

No  

 

 

 

 

 


Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

 

Yes  

 

No  

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer," “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer  

Accelerated filer  

Non-accelerated filer  

Smaller reporting company  

 

 

 

 

Emerging growth company  

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

 

Indicate by check mark whether the Registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.  

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

 

Yes  

 

No  

 

As of June 30, 2020, the last business day of the registrant's most recently completed second fiscal quarter, the aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant was approximately $487.1 million based on the price at which the shares were last sold for such date on The Nasdaq Stock Market LLC.

 

As of February 19, 2021, 49,151,491 shares of common stock were outstanding.

 

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the registrant's Proxy Statement for the 2021 Annual Meeting of Stockholders are incorporated by reference into Part III of this Form 10-K.

 

2


Tivity Health, Inc.

Form 10-K

 

Table of Contents

 

 

 

 

Page

Part I

 

 

 

 

Item 1.

Business

4

 

Item 1A.

Risk Factors

9

 

Item 1B.

Unresolved Staff Comments

18

 

Item 2.

Properties

18

 

Item 3.

Legal Proceedings

19

 

Item 4.

Mine Safety Disclosures

19

 

 

 

 

Part II

 

 

 

 

Item 5.

Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

20

 

Item 6.

Selected Financial Data

22

 

Item 7.

Management's Discussion and Analysis of Financial Condition and Results of Operations

24

 

Item 7A.

Quantitative and Qualitative Disclosures About Market Risk

36

 

Item 8.

Financial Statements and Supplementary Data

38

 

Item 9.

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

76

 

Item 9A.

Controls and Procedures

76

 

Item 9B.

Other Information

76

 

 

 

 

Part III

 

 

 

 

Item 10.

Directors, Executive Officers and Corporate Governance

77

 

Item 11.

Executive Compensation

77

 

Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

77

 

Item 13.

Certain Relationships and Related Transactions, and Director Independence

77

 

Item 14.

Principal Accounting Fees and Services

78

 

 

 

 

Part IV

 

 

 

 

Item 15.

Exhibits, Financial Statement Schedules

79

 

Item 16.

Form 10-K Summary

84

 

3


PART I

As used throughout this Annual Report on Form 10-K (this “Report”), unless the context otherwise indicates, the terms “we,” “us,” “our,” “Tivity Health,” or the “Company” refer collectively to Tivity Health, Inc. and its wholly owned subsidiaries.

Item 1. Business

Overview

 

Tivity Health, Inc. (the “Company”), was founded and incorporated in Delaware in 1981.  Through our four programs, SilverSneakers® senior fitness, Prime® Fitness, WholeHealth LivingTM, and Wisely WellTM, we are focused on becoming the modern destination for healthy living, especially for seniors and older adults.   

 

We offer SilverSneakers to members of Medicare Advantage, Medicare Supplement, and group retiree plans.  We also offer Prime Fitness, a fitness facility access program, through commercial health plans, employers, and other sponsoring organizations.  Our national network of fitness centers delivers both SilverSneakers and Prime Fitness.  Our fitness networks encompass approximately 16,000 partner locations and nearly 1,000 alternative locations that provide classes outside of traditional fitness centers. We also offer virtual fitness experiences, including live instructor-led classes. Through our WholeHealth Living program, which we sell primarily to health plans, we offer a continuum of services related to complementary, alternative, and physical medicine.  Our WholeHealth Living network includes relationships with approximately 18,000 complementary, alternative, and physical medicine practitioner locations to serve individuals through health plans and employers who seek health services such as chiropractic care, acupuncture, physical therapy, occupational therapy, massage therapy, and more.  Finally, through our Wisely Well brand, we offer meals designed to support individuals and caregivers who are seeking meal convenience as well as those recovering after a hospitalization or living with chronic conditions.

Effective as of December 9, 2020, we completed the sale of Nutrisystem, Inc. (“Nutrisystem”), a wholly owned subsidiary of the Company that included the Nutrisystem® and South Beach Diet® programs, to KNS Acquisition Corp. (“Kainos”) pursuant to terms of a Stock Purchase Agreement (the “Purchase Agreement”), dated October 18, 2020, by and among the Company, Kainos, and Kainos NS Holdings LP.  At the closing (the “Closing”) of the transactions contemplated by the Purchase Agreement (the “Transactions”), Nutrisystem and its subsidiaries were acquired by, and became wholly owned subsidiaries of, Kainos.  Pursuant to the terms of the Purchase Agreement, Kainos paid to the Company an aggregate purchase price, after giving effect to customary indebtedness and cash adjustments, of approximately $559 million, which amount is subject to a customary working capital adjustment post-Closing.  We used the significant majority of the net proceeds from the divestiture to pay down $519 million of principal on the term loans under our Credit Agreement (as defined below).  Results of operations for Nutrisystem have been classified as discontinued operations for all periods presented in the consolidated financial statements, and all related assets and liabilities have been classified as discontinued operations at December 31, 2019.

The Company is headquartered at 701 Cool Springs Boulevard, Franklin, Tennessee 37067.

COVID-19

 

In January 2020, the Secretary of the U.S. Department of Health and Human Services (“HHS”) declared a national public health emergency due to a novel strain of coronavirus, which causes the disease known as “COVID-19.”  In March 2020, the World Health Organization characterized the outbreak of COVID-19 as a global pandemic, and COVID-19 continues to spread throughout the United States and other countries.  Many state and local governments, together with public health officials, have recommended and mandated precautions to mitigate the spread of COVID-19, including ordering closure of certain businesses and imposing stay-at-home orders and social distancing guidelines for individuals. Such measures have resulted in significantly reduced demand for many businesses that have continued in operation.  

 

By March 31, 2020, substantially all of the fitness centers in our national network were temporarily closed, which had an adverse impact on our results from continuing operations for the first quarter of 2020 because a significant portion of revenues from our SilverSneakers program is based on member visits to a fitness partner location. A substantial number of our fitness partner locations remained closed through April, with some locations

4


reopening in May and additional locations reopening in June and throughout the third quarter of 2020. Due to a resurgence of COVID-19 cases throughout the country, some fitness partner locations were closed again during the fourth quarter of 2020.  For the month of December 2020, approximately 74% of our fitness partner locations reported at least one visit from our SilverSneakers program.  From April through December 2020, the average monthly total participation levels of our SilverSneakers members were significantly below historical levels, and we also experienced a decline in paid subscribers for Prime Fitness, each of which adversely impacted revenues from continuing operations.  We are unable to predict with certainty how many of our fitness partner locations will be subject to any operational restrictions in the future and for what duration, or the level of member participation at our fitness partner locations.  

 

Customer and Partner Contracts

Except for Prime Fitness, our customer contracts generally have initial terms of approximately three years.  Some contracts allow the customer to terminate early and/or determine on an annual basis to which of their members they will offer our programs.  For Prime Fitness, our contracts with commercial health plans, employers, and other sponsoring organizations generally have initial terms of approximately three years, while individuals who purchase the Prime Fitness program through these organizations may cancel at any time (on a monthly basis) after an initial period of one to three months. Our fitness partner location contracts generally have initial terms ranging from one to three years and auto-renew for successive one-year renewal terms.

Business Strategy

 

Our strategy is to become the modern destination for healthy living.  We will expand beyond fitness by establishing an engagement platform that enables personalized member interaction with all of our offerings, and we will partner with other payors and service providers to aggregate services to members under the SilverSneakers umbrella.  The continued development of our suite of digital offerings will enable a more tailored, interactive, and impactful experience across a variety of areas, including fitness, social connection, community involvement, volunteering, and enrichment.  In addition, we plan to accelerate growth in our WholeHealth Living offering through market share expansion and improved technology.  

Segment and Major Customer Information

 

Following the sale of Nutrisystem in December 2020, we have one operating and reportable segment.  

During 2020, Humana, Inc. (“Humana”), United Healthcare, Inc. (“United Healthcare”), and Blue Cross Blue Shield Association (“BCBSA”, which relates to our Prime Fitness business) each comprised more than 10%, and together comprised 39%, of our revenues from continuing operations. Our primary contracts with each of Humana, United Healthcare, and BCBSA continue through December 31, 2022.  No other customer accounted for 10% or more of our revenues from continuing operations in 2020. See Note 17 of the notes to consolidated financial statements included in this report relating to revenues from external customers and customer concentration.

Competition

The healthcare industry is highly competitive, and the manner in which services are provided is subject to continual change. Other entities, whose financial and marketing resources may exceed our resources, may choose to initiate or expand programs in competition with our offerings.

We believe we have certain advantages over our competitors such as:

 

the brand recognition of our programs such as SilverSneakers;

 

our long-term relationships with health plans;

 

our proprietary class programming, including our growing digital programming;

 

the depth and breadth of our fitness center network relationships, which encompass approximately 16,000 partner locations; and

 

the trusting connections with our members developed over more than 25 years.  

5


However, we cannot assure you that we can compete effectively with other entities who provide similar services.

Industry Integration and Consolidation

Consolidation remains an important factor in all aspects of the healthcare industry.  While we believe the size of our membership base provides us with the economies of scale to compete even in a consolidating market, we cannot assure you that we can effectively compete with companies formed as a result of industry consolidation or that we can retain existing customers if they are acquired by other entities that already have or contract for programs similar to ours or are not interested in our programs.

Governmental Regulation

Governmental regulation impacts us in a number of ways in addition to those regulatory risks presented under Item 1A. “Risk Factors” below.

Health Reform

In recent years, Congress and certain state governments have passed a large number of laws and regulations intended to result in major changes within the healthcare system. The Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010 (collectively, the “ACA”), the most prominent of these efforts, changes how healthcare services are covered, delivered, and reimbursed through, among other things, expanded health insurance coverage, reduced growth in Medicare program spending and the establishment of programs that tie reimbursement to care quality and value.

The ACA contains provisions that affect our customers, including commercial health plans and Medicare Advantage programs. Since 2010, when the ACA was enacted, the ACA has decreased the number of uninsured individuals, and expanded coverage through the expansion of public programs and private sector health insurance. However, the ACA also may increase costs and/or reduce the revenues of our customers or prospective customers. For example, the ACA prohibits commercial health plans from using gender, health status, family history, or occupation to set premium rates, eliminates pre-existing condition exclusions, and bans annual benefit limits. In addition, the ACA established uniform minimum medical loss ratios (“MLRs”) for health plans, requiring a minimum percentage of health coverage premium revenue to be spent on healthcare medical costs and quality improvement expenses. The ACA also reduced premium payments to Medicare Advantage plans such that the managed care per capita payments paid by HHS to Medicare Advantage plans are now, on average, approximately equal to those for traditional Medicare.  There is substantial uncertainty regarding the ongoing effects of the ACA because the Trump administration and Congress have made significant changes to the ACA, its implementation and its interpretation. Final rules issued in 2018 expand the availability of association health plans and allow the sale of short-term, limited-duration health plans, neither of which are required to cover all of the essential benefits mandated by the ACA.  Effective January 2019, Congress eliminated the financial penalty associated with the ACA’s individual mandate. In December 2018, a federal court in Texas ruled that the individual mandate was unconstitutional as a result of this change and determined that the rest of the ACA was, therefore, invalid. In December 2019, the Fifth Circuit Court of Appeals upheld this decision with respect to the individual mandate, but remanded for further consideration of how this affects the rest of the law. On November 10, 2020, the Supreme Court heard oral arguments regarding this case, and the law remains in place pending the appeals process. It is difficult to predict whether, when or how the ACA will be further changed, what alternative provisions, if any, will be enacted, the timing of implementation of any alternative provisions, the impact of alternative provisions on providers and other healthcare industry participants, and the ultimate outcome and impact of court challenges. The healthcare industry remains subject to ongoing health reform initiatives. For example, beginning in 2020, the Creating High-quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2018 (“Chronic Care Act”) allows Medicare Advantage plans to cover supplemental benefits that are not primarily health-related, but that have the reasonable expectation of improving or maintaining health.  Additionally, some members of Congress have proposed measures that would expand government-sponsored coverage, including single-payor proposals (often referred to as "Medicare for All"). Further, the potential impact of the 2020 federal election on health reform efforts is unknown.

Other Laws

While many of the governmental and regulatory requirements affecting healthcare delivery generally do not directly apply to us, our customers must comply with a variety of regulations including those governing Medicare

6


Advantage plans and their marketing and the licensing and reimbursement requirements of federal, state and local agencies. Certain of our services, including health service utilization management and certain claims payment functions, require licensure by state government agencies. We are subject to a variety of legal requirements in order to obtain and maintain such licenses.

Federal privacy regulations issued pursuant to the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) extensively restrict the use and disclosure of individually-identifiable health information by health plans, most healthcare providers, and certain other entities (collectively, “covered entities”). Federal security regulations issued pursuant to HIPAA require covered entities to implement and maintain administrative, physical and technical safeguards to protect the confidentiality, integrity and availability of electronic individually-identifiable health information. Because we handle individually-identifiable health information on behalf of covered entities, we are considered a "business associate" and are required to comply with most aspects of the HIPAA privacy and security regulations. Violations of HIPAA and its implementing regulations may result in criminal penalties and in substantial civil penalties for each violation. These penalties are updated annually based on changes to the consumer price index.

In the event of a data breach involving individually-identifiable health information, we are subject to contractual obligations and state and federal requirements that require us to notify our customers. These requirements may also require us or our customers to notify affected individuals, regulatory agencies, and the media of the data breach. Under HIPAA, non-permitted uses and disclosures of unsecured individually identifiable health information are presumed to be breaches for which notice is required, unless it can be demonstrated that there is a low probability the information has been compromised.

In addition, there are numerous other laws and legislative and regulatory initiatives at the federal and state levels addressing the confidentiality and security of confidential personal information that may apply to us directly or us contractually. These laws vary, are subject to frequent changes and updates in regulations, and could impose additional penalties and other legal liability. For example, the potential effects of the CCPA (as defined under Item 1A “Risk Factors”) are far-reaching and may require us to modify our data processing practices and policies and to incur substantial costs and expenses in an effort to comply. In addition, the Federal Trade Commission uses its consumer protection authority to initiate enforcement actions in response to data use and data breaches. If we fail to comply with these or other applicable laws and regulations, we could be subject to liabilities, including civil penalties, money damages, and criminal penalties.

Federal law contains various prohibitions related to false statements and false claims, some of which apply to private payors as well as federal programs. Our contracts with Medicare Advantage plans may subject us to a number of obligations, including billing and reimbursement requirements, prohibitions on fraudulent and abusive conduct and related training and screening obligations. Actions may be brought under the federal False Claims Act by the government as well as by private individuals, known as “whistleblowers,” who are permitted to share in any settlement or judgment. Liability under the federal False Claims Act arises when an entity knowingly submits a false claim for reimbursement to the federal government. The federal False Claims Act defines the term “knowingly” broadly. There are many other potential bases for liability under the federal False Claims Act, including knowingly and improperly avoiding repayment of an overpayment received from the government and the knowing failure to report and return an overpayment within 60 days of identifying the overpayment. The submission of claims for services or items generated in violation of certain “fraud and abuse” provisions of the Social Security Act, including the anti-kickback provisions, constitutes a false or fraudulent claim under the federal False Claims Act. In some cases, whistleblowers, the federal government, and some courts have taken the position that entities that allegedly have violated other statutes, such as the federal self-referral prohibition commonly known as the Stark Law, have thereby submitted false claims under the federal False Claims Act.

From time to time, participants in the healthcare industry, including the Company and our customers, may be subject to actions under the federal False Claims Act or other fraud and abuse laws, including similar state statutes, and it is not possible to predict the impact of such actions. Violations of applicable laws may result in significant civil and criminal penalties. For example, violations of the federal False Claims Act may result in penalties of three times the actual damages sustained by the government, plus substantial mandatory civil penalties for each separate false claim. These penalties are updated annually based on changes to the consumer price index.

7


Because of the international operations previously conducted as part of our total population health services (“TPHS”) business that we sold to Sharecare, Inc. in July 2016, we were subject to the U.S. Foreign Corrupt Practices Act (the “FCPA”) and similar anti-bribery laws of other countries in which we provided services prior to the sale. The FCPA and similar antibribery laws generally prohibit companies and their intermediaries from making improper payments to government officials or other third parties for the purpose of obtaining or retaining business or gaining any business advantage. Failure to comply with the FCPA and similar legislation prior to the sale of our TPHS business could result in the imposition of civil or criminal fines and penalties.

Intellectual Property

We own numerous trademarks and other proprietary rights that are important to our business. Depending upon the jurisdiction, trademarks are valid as long as they are used in the regular course of trade and/or their registrations are properly maintained. We believe the protection of our trademarks, copyrights, domain names, trade dress, and trade secrets is important to our success. We protect our intellectual property rights by relying on a combination of watch services and trademark, copyright, trade dress and trade secret laws, and through the domain name dispute resolution system.

Human Capital Resources

 

Employee Profile

 

As of February 22, 2021, we had approximately 350 employees, comprised of 35% male and 65% female.  Of our total employees, 54% were based out of our office in Chandler, Arizona, 13% were based out of our office in Franklin, Tennessee, and the remaining 33% were based off-campus within the United States.  We believe we have good relationships with our employees, and we encourage open and candid communication to ensure we maintain positive relationships.

 

Health and Safety

 

We are committed to the health and safety of our employees.  We have implemented health and safety policies and practices, taking into account CDC guidance and any applicable state or local requirements, to reduce the transmission of COVID-19, including adopting flexible work-from-home arrangements, imposing travel restrictions, promoting social distancing, and increasing cleaning protocols at our two office locations.  Since March 2020, we have not required our employees to work in the office; in June 2020, we began allowing employees to work in the office at their election, with increased office sanitation measures and the expectation that employees are adhering to social distancing and mask protocols.

 

Diversity and Inclusion

 

We embrace diversity and inclusion and believe in creating an inclusive and equitable environment that represents a broad spectrum of backgrounds and cultures.  Our CEO has pledged his commitment to the CEO Action for Diversity & InclusionTM, which outlines a specific set of actions the CEO will take to cultivate a trusting environment where all ideas are welcomed, and employees feel comfortable and empowered to have discussions about diversity and inclusion.  To further this effort and in addition to our existing communication vehicles, we have created an internal diversity and inclusion council, launched a diversity-focused listening series, and conducted unconscious bias training sessions with our employees. With the assistance of our diversity and inclusion council, we continue to explore additional diversity and inclusion initiatives.

 

Employee Engagement

We regularly conduct anonymous surveys to seek feedback from our employees on a variety of topics, including but not limited to, confidence in Company leadership, competitiveness of our compensation and benefits package, career growth opportunities and improvements on how we could make our Company an employer of choice. The results are shared with the entire organization and are reviewed by senior leadership, who analyze areas of progress or deterioration and prioritize actions and activities in response to this feedback to drive meaningful improvements in employee engagement.  We have also established regular communication between the CEO and employees.  Finally, we monitor employee turnover, with a particular emphasis on regretted turnover, and conduct exit interviews with departing employees.

8


Available Information

Our Internet address is www.tivityhealth.com. We make available free of charge, on or through our Internet website, our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as soon as reasonably practicable after we electronically file such material with, or furnish it to, the Securities and Exchange Commission (the “SEC”). The SEC maintains an Internet site that contains periodic reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC at www.sec.gov.

Item 1A. Risk Factors

In the execution of our business strategy, our operations and financial condition are subject to certain risks.  A summary of certain material risks is provided below, and you should take such risks into account in evaluating any investment decision involving the Company. This section does not describe all risks applicable to us and is intended only as a summary of certain material factors that could impact our operations in the industry in which we operate. Other sections of this report contain additional information concerning these and other risks.

 

Risks Relating to Our Business Generally

 

The COVID-19 pandemic has had, and is expected to continue to have, a material adverse effect on our business and results of operations.

 

As a result of the COVID-19 pandemic, by March 31, 2020, substantially all of the fitness centers in our national network were temporarily closed.  A substantial number of our fitness partner locations remained closed through April 2020.  Although some locations reopened in May 2020 and additional locations reopened in June and throughout the third quarter of 2020, the average monthly total participation levels of our members after such locations reopened were significantly below historical levels, thus adversely impacting our revenues during the second, third and fourth quarters of 2020.  There is considerable uncertainty regarding the extent to which COVID-19 will continue to spread and the extent and duration of measures to try to contain the virus, such as travel bans and restrictions, quarantines, shelter-in-place orders and business and government shutdowns. Although some restrictions have eased in some jurisdictions, rates of COVID-19 infection in regions across the United States and the world have remained high in recent months, and some areas are re-imposing closures and other restrictions due to such high rates of COVID-19 cases. As a result, the COVID-19 pandemic is significantly affecting, and is likely to continue to affect, overall economic conditions in the United States.

 

We have faced and may continue to face reclosures and/or long-term closures and other operational restrictions with respect to some or all of our fitness partner locations for prolonged periods of time due to, among other factors, evolving governmental restrictions including public health directives, quarantine policies, or social distancing measures.  Additionally, even if fitness partner locations are open, members may avoid public gathering places because of a perceived risk of infection or risk to health, which could reduce overall demand and adversely impact their use of our services.  Because a significant portion of our revenues from our SilverSneakers program is based on member visits to a fitness partner location, this decrease in member participation has affected and could further adversely affect our business and results of operations.

 

The extent to which COVID-19 continues to affect our results will depend on future developments, including whether there are additional outbreaks, mutations, variants, or related strains of the virus in locations where we operate, and the availability of, and prevalence of access to, effective medical treatments and vaccines for COVID-19, which are highly uncertain and cannot be predicted.

 

Consumer spending generally may also be negatively impacted by adverse general macroeconomic conditions and reduced consumer confidence, including the impacts of any recession resulting from the COVID-19 pandemic. This has negatively impacted, and may further negatively impact, the number of paid subscribers in our Prime Fitness program.

 

9


As a result of the COVID-19 pandemic, including related governmental guidance or requirements, we have implemented a work-from-home policy for our employees, which may negatively impact productivity and cause other disruptions to our business.  We closed our corporate offices and/or call centers from mid-March through May and began reopening our corporate offices on a limited basis in June as we continue to prioritize the safety and well-being of our employees.  We have incurred, and may incur in the future, costs related to implementing our work-from-home policy as well as additional cleaning fees and supplies related to the COVID-19 pandemic.  

 

We are uncertain of the potential long-term impacts of the COVID-19 pandemic on our business, and the severity, duration, and timing of the business and economic impacts from the continuing, unprecedented public health effort to contain and combat the spread of COVID-19, which has previously included, and may in the future include, among other things, significant volatility in financial markets and a sharp decrease in the value of equity securities, including our common stock.

 

Our business strategy relating to the development and introduction of new products and services exposes us to risks such as limited customer and/or market acceptance and additional expenditures that may not result in additional net revenue.

 

An important component of our business strategy is to focus on new products and services that enable us to provide immediate value to our customers.  We cannot predict whether customers and/or the market will accept these new products and services, and if we fail to execute successfully on this strategy or to adapt this strategy as market conditions evolve, our ability to grow revenue and our results of operations may be adversely affected.

 

If we fail to successfully implement our business strategy, our financial performance and our growth could be materially and adversely affected.

 

Our future financial performance and success are dependent in large part upon our ability to implement our business strategy successfully. Implementation of our strategy will require effective management of our operational, financial and human resources and will place significant demands on those resources. See Part I, Item 1. “Business – Business Strategy" in this report for more information regarding our business strategy.  There are risks involved in pursuing our strategy, including the ability to hire or retain the personnel necessary to manage our strategy effectively.

 

In addition to the risks set forth above, implementation of our business strategy could be affected by a number of factors beyond our control, such as epidemics and pandemics, including the ongoing COVID-19 pandemic (including responses of governmental authorities to contain such epidemics and pandemics), increased competition, legal developments, government regulation, general economic conditions, increased operating costs or expenses, and changes in industry trends. We may decide to alter or discontinue certain aspects of our business strategy at any time. If we are not able to implement our business strategy successfully, our long-term growth and profitability may be adversely affected. Even if we are able to implement some or all of the initiatives of our business strategy successfully, our operating results may not improve to the extent we anticipate, or at all.

 

We may experience difficulties associated with the implementation and/or integration of new businesses, services (including outsourced services), technologies, solutions, or products.

 

We may face difficulties, costs, and delays in effectively implementing and/or integrating acquired businesses, services (including outsourced services), technologies, solutions, or products into our business.  Implementing internally-developed solutions and products, and/or integrating newly acquired businesses, services (including outsourced services), and technologies could be time-consuming and may strain our resources. Consequently, we may not be successful in implementing and/or integrating these new businesses, services, technologies, solutions, or products and may not achieve anticipated revenue and cost benefits.

 

Changes in macroeconomic conditions and certain market risks may adversely affect our business.

 

Economic difficulties and other macroeconomic conditions (including any downturn or recession caused by the COVID-19 pandemic) could reduce the demand and/or the timing of purchases for certain of our services from customers and potential customers.  In addition, changes in economic conditions could create liquidity and credit constraints. We cannot assure you that we would be able to secure additional financing if needed and, if such funds were available, that the terms and conditions would be acceptable to us.

 

10


Certain of our interest rate swap agreements do not qualify for hedge accounting treatment, which may result in volatility in our U.S. GAAP earnings.

 

We maintain five interest rate swap agreements with current notional amounts totaling $311.1 million that do not qualify for hedge accounting treatment (“de-designated swaps”).  The de-designated swaps are recorded at their estimated fair value in the consolidated balance sheet, with changes in fair value recognized each period in current earnings.  Such changes may result in volatility in our U.S. GAAP earnings and may adversely affect the price of our common stock.

 

We have a significant amount of goodwill and intangible assets, the value of which could become further impaired.

 

We have recorded significant portions of the purchase price of certain acquisitions as goodwill and/or intangible assets. We review goodwill and intangible assets not subject to amortization for impairment on an annual basis (during the fourth quarter) or more frequently whenever events or circumstances indicate that the carrying value may not be recoverable. The COVID-19 pandemic has had and is having an adverse impact on the overall economy, resulting in rapidly changing market and economic conditions that have impacted the Company.  In March 2020, we experienced a significant decline in the Company’s market capitalization and in our actual and forecasted operating results, in addition to the unfavorable change in market conditions.  As a result, management concluded that there were triggering events during the first quarter of 2020 necessitating an impairment evaluation of our goodwill and indefinite-lived intangible assets (which consist of the Nutrisystem tradename and the SilverSneakers tradename).  Following these evaluations, we recorded a total impairment loss of $199.5 million related to the Nutrisystem goodwill and tradename during the first quarter of 2020, which amount is reflected in loss from discontinued operations.  We determined there was no impairment related to the SilverSneakers tradename or the carrying value of goodwill related to continuing operations.  During the third and fourth quarters of 2020, we recorded additional impairment losses of $66.2 million and $24.0 million related to the Nutrition business, each of which is reflected in loss from discontinued operations. At December 31, 2020, we had approximately $334.7 million and $29.0 million of goodwill and intangible assets, respectively, remaining.  If we determine that the carrying values of our goodwill and/or intangible assets related to continuing operations should be impaired, we may incur non-cash charges to earnings, which could have a material adverse effect on our results of continuing operations for the period in which the impairment occurs.

 

In order to be successful, we must attract, engage, retain and integrate key employees and have adequate succession plans in place, and failure to do so could have an adverse effect on our ability to manage our business.

 

Our success depends, in large part, on our ability to attract, engage, retain and integrate qualified executives and other key employees throughout all areas of our business. Identifying, developing internally or hiring externally, training and retaining highly skilled managerial and other personnel are critical to our future, and competition for experienced employees can be intense. Failure to successfully recruit executives and key employees or the loss of any executives and key employees could have a significant impact on our operations. The loss of services of any key personnel, the inability to retain and attract qualified personnel in the future, or delays in hiring may harm our business and results of operations. Further, changes in our management team may be disruptive to our business, and any failure to successfully integrate key newly hired employees could adversely affect our business and results of operations.

 

We face competition for staffing, which may increase our labor costs and reduce profitability.

 

We compete with other healthcare and services providers in recruiting qualified management, including executives with the required skills and experience to operate and grow our business, and staff personnel for the day-to-day operations of our business. These challenges may require us to enhance wages and benefits to recruit and retain qualified management and other professionals. Difficulties in attracting and retaining qualified management and other professionals, or in controlling labor costs, could have a material adverse effect on our profitability.

 

We are or may become a party to litigation that could potentially force us to pay significant damages and/or harm our reputation.

 

We are subject to certain legal proceedings, which potentially involve large claims and significant defense costs

11


(see Note 11 of the notes to consolidated financial statements included in this report). These legal proceedings and any other claims that we may face in the future, whether with or without merit, could result in costly litigation, and divert the time, attention, and resources of our management. The coverage limits of our insurance policies may not be adequate to cover all such claims and some claims may not be covered by insurance. Additionally, insurance coverage with respect to some claims against us or our directors and officers may not be available on terms that would be favorable to us.  The cost of such coverage has increased in recent years and could further increase in the future.  Further, although we believe that we have conducted our operations in compliance with applicable statutory and contractual requirements and that we have meritorious defenses to outstanding claims, it is possible that resolution of these legal matters could have a material adverse effect on our results of operations.  In addition, legal expenses associated with the defense of these matters may be material to our results of operations in a particular financial reporting period.

 

Damage to our reputation could harm our business, including our competitive position and business prospects.

 

Our ability to attract and retain customers, members and employees is impacted by our reputation. Harm to our reputation can arise from various sources, including employee misconduct, cyber security breaches, unethical behavior, litigation or regulatory outcomes, which could, among other consequences, increase the size and number of litigation claims and damages asserted or subject us to enforcement actions, fines and penalties and cause us to incur related costs and expenses.

 

Our results of operations could be adversely affected by severe or unexpected weather, epidemics, pandemics or outbreaks of disease.

 

Adverse weather conditions or other extreme changes in the weather may cause people to refrain, or prevent people, from visiting fitness partner locations and using our services.  Additionally, widespread health epidemics or outbreaks of disease, such as influenza or COVID-19, may cause members to avoid public gathering places and negatively impact their use of our services.  As some of the fees that we charge our customers are based on member participation, a decrease in member participation could adversely affect our business and results of operations.

 

If our customers or fitness center partners experience financial distress, or seek to change or delay payment terms, it could negatively affect our financial position and results.

 

At any given time, one or more of our customers or fitness center partners may experience financial difficulty, file for bankruptcy protection or go out of business. Unfavorable economic and financial conditions, such as the current events surrounding the COVID-19 pandemic, could result in an increase in our customers’ or fitness center partners’ financial difficulties that then affect us.  The direct impact on us could include reduced revenues and write-offs of accounts receivable and could negatively impact our operating cash flow. While we currently cannot estimate what those effects will be, if they are severe, the indirect impact could include impairments of intangible assets and reduced liquidity, among others.

 

If our efforts to attract and retain paying subscribers for our Prime Fitness program are not successful, our business will be adversely affected.

 

Our ability to continue to attract paying subscribers for our Prime Fitness program will depend in part on our ability to offer convenience and value to our Prime Fitness subscribers and our partners’ ability to effectively market the program. Our ability to attract and retain paying subscribers may be adversely affected by our competitors' relative offerings, pricing, and other factors, as well as other fitness programs (including digital offerings) in the marketplace. If our Prime Fitness subscribers do not perceive our products to be of value, we may not be able to attract and retain Prime Fitness subscribers. Additionally, COVID-19 has adversely impacted and may continue to adversely impact our ability to attract and retain subscribers for our Prime Fitness program. We must continually add new Prime Fitness paying subscribers both to replace canceled subscriptions and to grow our Prime Fitness program beyond our current subscriber base. Further, if excessive numbers of our Prime Fitness subscribers cancel their subscriptions, in connection with COVID-19 or otherwise, our results of operations will be adversely affected.

 

We could be adversely affected by violations of the FCPA and similar anti-bribery laws of other countries in

12


which we provided services prior to the sale of our TPHS business.

 

Because of the international operations that we previously conducted as part of our TPHS business that we sold to Sharecare, Inc. in July 2016, we could be adversely affected by violations of the FCPA and similar anti-bribery laws of other countries in which we provided services prior to the sale. The FCPA and similar anti-bribery laws generally prohibit companies and their intermediaries from making improper payments to government officials or other third parties for the purpose of obtaining or retaining business or gaining any business advantage. While our policies mandated compliance with these anti-bribery laws, we cannot provide assurance that our internal control policies and procedures always protected us from reckless or criminal acts committed by our employees, contractors or agents. Failure to comply with the FCPA and similar legislation prior to the sale of our TPHS business could result in the imposition of civil or criminal fines and penalties and could disrupt our business and adversely affect our results of operations, cash flows and financial condition.

 

Risks Relating to the Healthcare Industry

 

A significant percentage of our revenues is derived from health plan customers.

 

A significant percentage of our revenues is derived from health plan customers. The health plan industry may continue to consolidate, and we cannot assure you that we will be able to retain health plan customers, or continue to provide our products and services to such health plan customers on terms at least as favorable to us as currently provided, if they are acquired by other health plans that already participate in competing programs or are not interested in our programs. Increasing vertical integration efforts involving health plans and healthcare providers or entities that provide wellness services may increase these challenges. Our health plan customers that are part of larger healthcare enterprises may have greater bargaining power, which may lead to further pressure on the prices for our products and services. In addition, a reduction in the number of covered lives enrolled with our health plan customers or in the payments we receive could adversely affect our results of operations. Our health plan customers are subject to continuing competition and reduced reimbursement rates from governmental and private sources, which could lead current or prospective customers to seek reduced fees or choose to reduce or delay the purchase of our services. Finally, health plan customers could offer (and in some cases are offering) services themselves that compete directly with our offerings, stop providing our offerings to certain or all of their members (as one of our customers, United Healthcare, has done), or offer fitness benefits in addition to SilverSneakers and Prime Fitness, which could adversely affect our business and results of operations.

 

We currently derive a significant percentage of our revenues from three customers.

 

For the year ended December 31, 2020, three customers each comprised more than 10%, and together comprised approximately 39%, of our revenues from continuing operations. Our primary contracts with these customers continue through December 31, 2022. The loss or restructuring of a contract with any of these customers or any of our other significant customers could have a material adverse effect on our business and results of operations.  None of these three contracts allows the customer to terminate for convenience prior to the expiration of the contract.

 

Our inability to renew and/or maintain contracts with our customers and/or fitness partner locations under existing terms or restructure these contracts under favorable terms could adversely affect our business and results of operations.

 

If our customers and/or fitness partner locations choose not to renew their contracts with us (which occurs from time to time), our business and results of operations could be materially adversely affected.  Loss of a significant fitness partner or health plan customer or a reduction in a health plan customer's enrolled lives (including as a result of increased unemployment and the resulting loss of health insurance coverage) could have a material adverse effect on our business and results of operations.  In addition, a restructuring of a contract with a health plan customer and/or fitness partner on terms that aren’t favorable to us could adversely affect our business and results of operations. Moreover, the businesses of our fitness partner locations have been and will likely continue to be adversely affected by the closure of locations, any public health directives, or social distancing measures applicable upon reopening of locations and reduced overall consumer demand for fitness center use as a result of the COVID-19 pandemic.  If a significant portion of our fitness partner network is unable to return to normal operations within a reasonable period of time as a result of financial or operational stresses brought on by the COVID-19 pandemic, we may be unable to make alternative arrangements with substitute fitness partners on favorable terms or at all.

 

13


Reductions in Medicare Advantage health plan reimbursement rates or changes in plan designs may negatively impact our business and results of operations.

 

A significant portion of our revenue is indirectly derived from the monthly premium payments paid by the U.S. Department of Health and Human Services to our health plan customers for services they provide to Medicare Advantage beneficiaries.  As a result, our results of operations are, in part, dependent on government funding levels for Medicare Advantage programs. An executive order issued in October 2019 seeks to encourage innovative Medicare Advantage benefit structures and plan designs, including through changes to supplemental benefits.  Any changes that limit or reduce Medicare Advantage reimbursement levels, such as reductions in or limitations of reimbursement amounts or rates under these programs, reductions in funding of these programs, expansion of benefits without adequate funding, elimination of coverage for certain benefits, or elimination of coverage affecting the services that we provide, could have a material adverse effect on our health plan customers, and as a result, on our business and results of operations.

 

Compliance with existing or newly adopted federal and state laws and regulations or new or revised interpretations of such requirements could adversely affect our results of operations or may require us to spend substantial amounts, and the failure to comply with applicable laws and regulations could subject us to penalties or negatively impact our ability to provide services.

 

Our customers are subject to considerable state and federal government regulation, and a substantial majority of our business involves providing services to Medicare Advantage beneficiaries. As a result, we are subject directly to various federal laws and regulations, including the federal False Claims Act, billing and reimbursement requirements and other provisions related to fraud and abuse. In addition, our contracts with Medicare Advantage plans require us to comply with a number of regulatory provisions and to permit these health plan customers to perform compliance audits of our processes and programs. Many of these regulations are vaguely written and subject to differing interpretations that may, in certain cases, result in unintended consequences that could impact our ability to effectively deliver services. Further, we are required to comply with most requirements of the HIPAA privacy and security laws and regulations and may be subject to criminal or civil penalties for violations of these regulations. Certain of our services, including health utilization management and certain claims payment functions, require licensure and may be regulated by government agencies. We are subject to a variety of legal requirements in order to obtain and maintain such licenses, but little guidance is available to determine the scope of some of these requirements.

 

We continually monitor the extent to which federal and state legislation and regulations govern our operations. New federal or state laws or regulations or new interpretations of existing requirements that affect our operations could have a material adverse effect on our results of operations. If we are found to have violated applicable laws, to have caused any of our customers to submit false claims or make false statements, or to have failed to comply with our contractual compliance obligations, we could be required to restructure our operations, be subject to contractual penalties, including termination of our customer agreements, and be subject to significant civil and criminal penalties.

 

Healthcare reform efforts may result in a reduction to our revenues from government health programs and private insurance companies or otherwise directly or indirectly impact our business.

 

The healthcare industry is subject to various political, regulatory, scientific, and technological influences. Efforts at federal and state levels of government have resulted in laws and regulations intended to effect significant change within the healthcare system. The ACA, the most prominent of these efforts, affects coverage, delivery, and reimbursement of healthcare services. Among other effects, several of its provisions may increase the costs and/or reduce the revenues of our customers or prospective customers. For example, the ACA eliminates pre-existing condition exclusions by commercial health plans, bans annual benefit limits, and mandates minimum medical loss ratios for health plans.

 

However, there is substantial uncertainty regarding the net effect and future of the ACA. The Trump administration and Congress have made significant changes to the ACA, its implementation and its interpretation.  Effective January 2019, Congress eliminated the penalty associated with the ACA’s individual mandate.  As a result, a federal court in Texas ruled in December 2018 that the individual mandate was unconstitutional and determined that the rest of the ACA was, therefore, invalid.  In December 2019, the Fifth Circuit Court of Appeals upheld this decision with respect to the individual mandate, but remanded for further consideration of how this affects the rest of the law. On November 10, 2020, the Supreme Court heard oral arguments regarding this case,

14


and the law remains in place pending the appeals process.  It is possible that the reforms imposed by the ACA or uncertainty regarding significant changes or court challenges to the law will adversely affect the profitability of our customers and cause our customers or prospective customers to reduce or delay the purchase of our services or to demand reduced fees. Because of this uncertainty and many other variables, including the ACA’s complexity and the difficulty of predicting the impact of changes on other healthcare industry participants and the ultimate outcome of court challenges, we are unable to predict all of the ways in which the ACA could impact us. Furthermore, we could also be impacted by other legislative and regulatory healthcare reform initiatives.  For example, the Chronic Care Act of 2018 allows Medicare Advantage plans, starting in 2020, to cover supplemental benefits that are not primarily health-related, but that have the reasonable expectation of improving or maintaining health. Additionally, some members of Congress have proposed measures that would expand government-sponsored coverage, including single-payor proposals (often referred to as "Medicare for All"). Further, the potential impact of the 2020 federal election on health reform efforts is unknown.

 

Risks Relating to Information Technology, Data Privacy and Intellectual Property

 

A failure of our information technology or systems could adversely affect our business.

 

Our ability to deliver our products and services depends on effectively using information technology.  We rely upon our information technology and systems, employees, and third parties for operating and monitoring all major aspects of our business. These technologies and systems and, therefore, our operations could be damaged or interrupted by natural disasters, power loss, network failure, improper operation by our employees, data privacy or security breaches, computer viruses, computer hacking, network penetration or other illegal intrusions, epidemics or pandemics (such as the COVID-19 pandemic), or other unexpected events. Any disruption in the operation of our information technology or systems, regardless of the cause, could adversely impact our operations, which may adversely affect our financial condition, results of operations and cash flows.

 

A cybersecurity incident could result in the loss of confidential data, give rise to remediation and other expenses, expose us to liability under HIPAA, consumer protection laws, common law theories or other laws, subject us to litigation and federal and state governmental inquiries, damage our reputation, and otherwise be disruptive to our business.

 

The nature of our business involves the receipt, storage and use of personal data about the participants in our programs, including individually identifiable health information, as well as employees and customers. Additionally, we rely upon third parties that are not directly under our control to store and use portions of that personal data as well.  The secure maintenance of this and other confidential information or other proprietary information is critical to our business operations. To protect our information systems from attack, damage and unauthorized use or disclosure, we have implemented multiple layers of security, including technical safeguards, processes, and our people. Our defenses are monitored and routinely tested internally and by external parties. In addition, we are Health Information Trust Alliance (“HITRUST”) certified, which enables us to demonstrate compliance with industry-defined risk management and data protection requirements based on a standardized framework. Despite these efforts, threats from malicious persons and groups, new vulnerabilities, technology failures, and advanced attacks against information systems create risk of cybersecurity incidents, which are rapidly evolving and increasingly sophisticated. Personnel error or malfeasance, faulty password management, social engineering or other vulnerabilities and irregularities may also result in a defeat of our or our third-party service providers' security measures and a breach of our or their information systems. Moreover, hardware, software or applications we use may have inherent vulnerabilities or defects of design, manufacture or operations or could be inadvertently or intentionally implemented or used in a manner that could compromise information security. Therefore, we cannot provide assurance that we or our third-party vendors or other service providers will not be subject to cybersecurity incidents or occurrences, which may result in unauthorized access by third parties, loss, modification, misappropriation, disclosure or corruption of customer, employee, or our information; member protected health information; or other data subject to privacy laws, or that otherwise disable or degrade our systems, disrupt our customers’ experience and our ability to efficiently operate our business. In addition, COVID-19 may have an adverse impact on our information technology systems and our ability to securely preserve confidential information, including as a result of telecommuting issues associated with our employees working remotely. Such cybersecurity incidents or delays in responding to or remedying damage caused by such incidents may lead to a disruption in our systems or business, costs to modify, enhance, or remediate our cybersecurity measures, liability under privacy, security and consumer protection laws or litigation under these or other laws,

15


including common law theories, and subject us to enforcement actions, fines, regulatory proceedings or litigation against us, damage to our business reputation, a reduction in participation and sales of our products and services, and legal obligations to notify customers or other affected individuals about an incident, which could cause us to incur substantial costs and negative publicity, any of which could have a material adverse effect on our financial condition and results of operations and harm our business reputation.

 

As a result, cybersecurity and the continued development and enhancement of our controls, processes and practices remain a priority for us. We may be required to expend significant additional resources in our efforts to modify or enhance our protective measures against evolving threats or to investigate and remediate any cybersecurity vulnerabilities.

 

Our business is subject to new and changing federal and state privacy and security laws, rules and regulations, which impact our operating costs and for which failure to adhere could negatively impact our business.

 

Our business is subject to various federal and state privacy and data security laws, rules and regulations. Some state laws and regulations may be inconsistent across jurisdictions and subject to evolving and differing (sometimes conflicting) interpretations and applications. While we are using internal and external resources to monitor compliance with and to continue to modify our data practices and policies in order to comply with evolving privacy laws, relevant regulatory authorities could determine that our data practices fail to address all the requirements of certain new or changing laws, which could subject us to penalties and/or litigation. Government regulators, privacy advocates and class action attorneys are increasingly scrutinizing how companies collect, process, use, store, share and transmit personal data. For example, the California Consumer Privacy Act of 2018 (“CCPA”), went into effect on January 1, 2020, and it applies broadly to information that identifies or is associated with any California household or individual, and compliance with the new law requires that we implement several operational changes, including processes to respond to individuals’ requests.  Moreover, the California Privacy Rights Act (“CPRA”) was recently approved by California voters as a ballot initiative and will take effect January 1, 2023, and significantly modifies the CCPA. Failure to comply with the CCPA and, after July 2023, the CPRA, may result in governmental enforcement actions, private claims, including class action lawsuits, and damage to our reputation. In addition, the CPRA creates a new enforcement agency charged with enforcing the CPRA and imposes additional requirements including privacy risk assessments and audits as well as vendor contractual requirements for data sharing, license and access arrangements. The CCPA and CPRA also provide for civil penalties for violations, as well as a private right of action for data breaches that may increase data breach litigation. We may also be exposed to litigation, regulatory fines, penalties or other sanctions if the personal, confidential or proprietary information of our customers is mishandled or misused by any of our suppliers, counterparties or other third parties, or if such third-parties do not have appropriate controls in place to protect such personal, confidential or proprietary information.  Additionally, the Federal Trade Commission (“FTC”) and many state attorneys general are interpreting federal and state consumer protection laws to impose standards for the collection, use, dissemination and security of data.  The obligations imposed by the CCPA and other similar laws that may be enacted at the federal and state level may require us to modify our business practices and policies and to incur substantial expenditures in order to comply.

 

Further, our marketing and member engagement activities may be subject to communications privacy laws such as the Telephone Consumer Protection Act, CAN-SPAM Act and FTC and Federal Communications Commission (“FCC”) rules and regulations. While we strive to adhere to strict policies and procedures that comply with such laws and regulations, we may be subjected to class action lawsuit settlements or penalties, and regulators and courts may disagree with our interpretation of these laws and regulations and subject us to penalties and other consequences for noncompliance. Determination by a court or regulatory agency that our marketing practices violate communications privacy laws could subject us to civil penalties and could require us to change some portions of our business. Even an unsuccessful challenge by consumers or regulatory authorities of our activities could result in adverse publicity and could require a costly response from and defense or settlement by us.

 

The impact of new laws, regulations and policies and the related interpretations, as well as changes in enforcement practices or regulatory scrutiny generally cannot be predicted, and changes in applicable laws, regulations and policies and the related interpretations and enforcement practices may require extensive system and operational changes, be difficult to implement, increase our operating costs, require significant capital

16


expenditures, or adversely impact the cost or attractiveness of the products or services we offer, or result in adverse publicity and harm our reputation.

 

Third parties may infringe on our brands, trademarks and other intellectual property rights, which may have an adverse impact on our business.

 

We currently rely on a combination of trademark and other intellectual property laws and confidentiality procedures to establish and protect our proprietary rights, including our brands. If we fail to successfully enforce our intellectual property rights, the value of our brands, services and products could be diminished and our business may suffer. Our precautions may not prevent misappropriation of our intellectual property. Any legal action that we may bring to protect our brands and other intellectual property could be unsuccessful and expensive and could divert management’s attention from other business concerns. In addition, legal standards relating to the validity, enforceability and scope of protection of intellectual property, especially in Internet-related businesses, are uncertain and evolving. We cannot assure you that these evolving legal standards will sufficiently protect our intellectual property rights in the future.

 

We may be subject to intellectual property rights claims.

 

Third parties may make claims against us alleging infringement of their intellectual property rights. Any intellectual property claims, regardless of merit, could be time-consuming and expensive to litigate or settle and could significantly divert management’s attention from other business concerns. In addition, if we were unable to successfully defend against such claims, we may have to pay damages, stop selling the service or product or stop using the software, technology or content found to be in violation of a third party’s rights, seek a license for the infringing service, product, software, technology or content or develop alternative non-infringing services, products, software, technology or content. If we cannot license on reasonable terms, develop alternatives or stop using the service, product, software, technology or content for any infringing aspects of our business, we may be forced to limit our service and product offerings. Any of these results could reduce our revenue and our ability to compete effectively, increase our costs or harm our business.

 

Risks Relating to our Credit Facility

 

The performance of our business (as it could further be affected by the COVID-19 pandemic) and the level of our indebtedness could prevent us from meeting the obligations under our Credit Agreement or have an adverse effect on our future financial condition, our ability to raise additional capital, or our ability to react to changes in the economy or our industry.

 

In connection with the consummation of the acquisition of Nutrisystem, on March 8, 2019, we entered into the Credit Agreement.  As of December 31, 2020, outstanding debt under the Credit Agreement was $466.7 million, which represented $496.3 million of principal on the term loans under the Credit Agreement less deferred loan costs and original issue discount.

 

Our ability to service our indebtedness will depend on our ability to generate cash in the future.  We cannot assure you that our business will generate sufficient cash flow from operations or that future borrowings will be available in an amount sufficient to enable us to service our indebtedness or to fund other liquidity needs.  If there are prolonged or worsening effects of the COVID-19 pandemic, such as long-term closures of our fitness partner locations, we could be unable to generate revenues and cash flows sufficient to conduct our business, service our outstanding debt, and comply with the covenants under the Credit Agreement.  This could, among other things, exhaust our available liquidity (and ability to access liquidity sources) and/or result in an acceleration of the maturity of a significant portion or all of our then-outstanding debt obligations, which we may be unable to repay or refinance.

 

The Credit Agreement contains various affirmative and negative covenants customary for financings of this type that, subject to certain exceptions, impose restrictions and limitations on us and certain of our subsidiaries with respect to, among other things, indebtedness; liens; negative pledges; restricted payments (including dividends, distributions, buybacks, redemptions, repurchases with respect to equity interests, and payments, redemptions, retirements, purchases, acquisitions, defeasance, exchange, conversion, cancellation or termination with respect to junior lien, subordinated or unsecured debt); restrictions on subsidiary distributions; loans, advances, guarantees, acquisitions and other investments; mergers and other fundamental changes; sales and other dispositions of assets (including equity interests in subsidiaries); sale/leaseback transactions; transactions with affiliates; conduct of

17


business; amendments and waivers of organizational documents and material junior debt agreements; and changes to fiscal year.

 

Our indebtedness could adversely affect our future financial condition or our ability to react to changes in the economy or industry by, among other things:

 

 

increasing our vulnerability to a downturn in general economic conditions (including any downturn or recession caused by the COVID-19 pandemic), loss of revenue and/or profit margins in our business, or to increases in interest rates, particularly with respect to the portion of our outstanding debt that is subject to variable interest rates;

 

potentially limiting our ability to obtain additional financing or to obtain such financing on favorable terms;

 

causing us to dedicate a portion of future cash flow from operations to service or pay down our debt, which reduces the cash available for other purposes, such as operations, capital expenditures, and future business opportunities; and

 

 

 

possibly limiting our ability to adjust to changing market conditions and placing us at a competitive disadvantage compared to competitors who may be less leveraged.

 

Our variable rate indebtedness subjects us to interest rate risk, which could cause our debt service obligations to increase significantly, and changes in LIBOR reporting practices could lead to an increase in the cost of our indebtedness and adversely affect our results of operations.

 

Borrowings under our Credit Agreement are at variable rates of interest, generally using LIBOR as the benchmark, and expose us to interest rate risk.  Interest rates are currently at historically low levels, but if interest rates increase, our debt service obligations with respect to our variable rate indebtedness would increase even if the amount borrowed remained the same, and our net income and cash flows would correspondingly decrease.

 

To mitigate our exposure to future interest rate volatility with respect to our variable rate indebtedness, we have entered into interest rate swaps and may in the future enter into additional interest rate swaps, which involve the exchange of floating for fixed rate interest payments. Considering hedging gains and losses and cash settlement costs, we may not elect to maintain such interest rate swaps, and any swaps may not fully mitigate our interest rate risk.

A transition away from LIBOR as a benchmark for establishing the applicable interest rate may adversely affect our variable rate debt and interest rate swaps.  The Financial Conduct Authority of the United Kingdom has announced that by the end of calendar year 2021 it will no longer require LIBOR submissions, resulting in the possible unavailability or lack of suitability of LIBOR as a benchmark rate. Discussions among the Financial Conduct Authority, the ICE Benchmark Administration and others regarding LIBOR cessation are ongoing, and a number of uncertainties remain. While our borrowing arrangements provide for alternative base rates as well as a method for selecting a benchmark replacement for LIBOR, the consequences of LIBOR becoming unavailable or not suitable at some point cannot be predicted with confidence at this time. Use of an alternative base rate or a benchmark replacement for LIBOR as a basis for calculating interest with respect to our outstanding variable rate indebtedness or interest rate swap agreements could lead to an increase in the interest we pay and a corresponding increase in the cost of our indebtedness, and could affect our ability to refinance some or all of our existing indebtedness or otherwise have a material adverse impact on our business, financial condition and results of operations.

Item 1B. Unresolved Staff Comments

None.

Item 2. Properties

As of December 31, 2020, we leased the following facilities:

 

18


Description of Use

 

Leased Square Footage

 

 

Square Footage Subleased to Other Tenants

 

Location

Office space

 

 

263,598

 

 

 

218,769

 

Franklin, Tennessee

Office space

 

 

45,085

 

 

 

 

Chandler, Arizona

Office space

 

 

6,361

 

 

 

 

Ashburn, Virginia

Total

 

 

315,044

 

 

 

218,769

 

 

 

For a description of material pending legal proceedings, see Note 11 of the notes to consolidated financial statements included in this report.

Item 4. Mine Safety Disclosures

Not applicable.

Information about our Executive Officers

The following table sets forth certain information regarding our executive officers as of March 2, 2021.  Executive officers of the Company serve at the pleasure of the Board of Directors of the Company.

 

Officer

 

Age

 

Position

 

 

 

 

 

Richard M. Ashworth

 

46

 

Chief Executive Officer of the Company since June 2020.  President of Walgreen Co. (“Walgreens”) from February 2020 to June 2020.  President of Operations of Walgreens from November 2017 to February 2020 and President of Pharmacy and Retail Operations of Walgreens from 2014 to 2017.

 

 

 

 

 

Adam C. Holland

 

42

 

Chief Financial Officer of the Company since June 2017.  Chief Financial Officer of Kirkland’s, Inc. (“Kirkland’s”) from February 2015 to June 2017, Chief Accounting Officer of Kirkland’s from August 2014 to February 2015 and Vice President of Finance of Kirkland’s from August 2008 to February 2015.

 

 

 

 

 

Ryan M. Wagers

 

43

 

Chief Accounting Officer of the Company since October 2018.  SVP, Chief Accounting Officer and Treasurer of Sitel Worldwide Corporation (“Sitel”) from November 2016 to October 2018.  SVP, Shared Services of Sitel, from February 2016 until November 2016 and Chief Accounting Officer of Sitel from 2011 to February 2016.

 

 

 

 

 

 

19


PART II

Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Market Information

Our common stock is traded on The Nasdaq Global Select Market (“Nasdaq”) under the symbol "TVTY".

 

Performance Graph

The following graph compares the total stockholder return of $100 invested on December 31, 2015 in (a) the Company, (b) the Nasdaq U.S. Stocks Benchmark index and (c) the Nasdaq Health Care index, assuming the reinvestment of all dividends.

The stock price performance shown on this graph is not necessarily indicative of future price performance.

 

Holders of Common Stock

At February 22, 2021, there were approximately 10,400 holders of our common stock, including 274 stockholders of record.

20


Dividends

We have never declared or paid a cash dividend on our common stock.  We intend to retain any earnings to finance the growth and development of our business and do not expect to declare or pay any cash dividends in the foreseeable future. Our Board of Directors reviews our dividend policy from time to time and may declare dividends at its discretion; however, our Credit Agreement places restrictions on the payment of dividends. For further discussion of the Credit Agreement, see Item 7. "Management's Discussion and Analysis of Financial Condition and Results of Operation - Liquidity and Capital Resources."

Securities Authorized for Issuance Under Equity Compensation Plans

See Part III, Item 12. "Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters," for information regarding securities authorized for issuance under our equity compensation plans, which is incorporated herein by reference.

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

The stock repurchase activity for the fourth quarter of 2020 was as follows:

 

ISSUER PURCHASES OF EQUITY SECURITIES

 

Period

 

Total Number of Shares Purchased (1)

 

 

Average Price Paid per Share

 

 

Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (2)

 

 

Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (2)

 

10/1/2020 - 10/31/2020

 

 

 

 

 

 

 

 

 

 

 

 

11/1/2020 - 11/30/2020

 

 

 

 

 

 

 

 

 

 

 

 

12/1/2020 - 12/31/2020

 

 

8,513

 

 

$

19.70

 

 

 

 

 

 

 

Total

 

 

8,513

 

 

$

19.70

 

 

 

 

 

 

 

 

(1)

Total shares purchased include shares attributable to the withholding of shares by Tivity Health to satisfy the payment of tax obligations related to the vesting of restricted shares.

 

(2)

We had no publicly announced plans or open market repurchase programs for shares of our common stock during the three months ended December 31, 2020.

Annual Report

A copy of the Tivity Health, Inc. Annual Report on Form 10-K for 2020 filed with the Securities and Exchange Commission is available on the Company's website, www.tivityhealth.com. It is also available from the Company (without exhibits) at no charge. These requests should be directed to Jill Meyer, Vice President – Corporate Communications, or Adam Holland, Chief Financial Officer, at the Company's corporate office.


21


Item 6. Selected Financial Data

 

The following table represents selected consolidated financial data. The table should be read in conjunction with Item 7. "Management's Discussion and Analysis of Financial Condition and Results of Operations" and Item 8. "Financial Statements and Supplementary Data" of this report.  As further discussed in Note 1 to the notes to the consolidated financial statements included in this report, our results from continuing operations do not include the results of the Nutrisystem and TPHS businesses, which we sold effective December 9, 2020 and July 31, 2016, respectively.

 

(In thousands, except per share data)

 

Year Ended December 31,

 

 

 

2020

 

 

2019

 

 

2018

 

 

2017

 

 

2016

 

Operating Results:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenues

 

$

437,714

 

 

$

633,066

 

 

$

606,299

 

 

$

556,942

 

 

$

500,998

 

Cost of revenue (exclusive of depreciation and

   amortization included below)

 

 

250,362

 

 

 

445,817

 

 

 

418,333

 

 

 

390,261

 

 

 

353,451

 

Marketing expenses

 

 

12,197

 

 

 

17,720

 

 

 

14,417

 

 

 

5,541

 

 

 

3,669

 

Selling, general and administrative expenses

 

 

42,991

 

 

 

53,198

 

 

 

35,077

 

 

 

34,164

 

 

 

39,478

 

Depreciation and amortization

 

 

9,930

 

 

 

7,137

 

 

 

4,667

 

 

 

3,357

 

 

 

4,085

 

Restructuring and related charges

 

 

4,358

 

 

 

1,881

 

 

 

124

 

 

 

3,223

 

 

 

4,933

 

Operating income

 

$

117,876

 

 

$

107,313

 

 

$

133,681

 

 

$

120,396

 

 

$

95,382

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

 

43,477

 

(1)

 

41,803

 

(1)

 

8,733

 

 

 

15,613

 

 

 

17,318

 

Income before income taxes

 

$

74,399

 

 

$

65,510

 

 

$

124,948

 

 

$

104,783

 

 

$

78,064

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income tax expense

 

 

17,530

 

(2)

 

20,293

 

(2)

 

27,046

 

(2)

 

43,553

 

(2)

 

21,973

 

Income from continuing operations

 

$

56,869

 

 

$

45,217

 

 

$

97,902

 

 

$

61,230

 

 

$

56,091

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) from discontinued operations, net of

   income tax

 

 

(280,500

)

 

 

(332,038

)

 

 

901

 

 

 

2,485

 

 

 

(184,706

)

Net income (loss)

 

$

(223,631

)

 

$

(286,821

)

 

$

98,803

 

 

$

63,715

 

 

$

(128,615

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Less: net income attributable to

   non-controlling interest

 

 

 

 

 

 

 

 

 

 

 

 

 

 

496

 

Net income (loss) attributable to Tivity Health

 

$

(223,631

)

 

$

(286,821

)

 

$

98,803

 

 

$

63,715

 

 

$

(129,111

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic income (loss) per share attributable to

   Tivity Health:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

$

1.17

 

 

$

0.97

 

 

$

2.44

 

 

$

1.56

 

 

$

1.52

 

Discontinued operations

 

 

(5.75

)

 

 

(7.14

)

 

 

0.02

 

 

 

0.06

 

 

 

(5.01

)

Net income (loss) (3)

 

$

(4.59

)

 

$

(6.17

)

 

$

2.47

 

 

$

1.62

 

 

$

(3.49

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted income (loss) per share attributable to

   Tivity Health:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

$

1.16

 

 

$

0.96

 

 

$

2.27

 

 

$

1.44

 

 

$

1.47

 

Discontinued operations

 

 

(5.70

)

 

 

(7.05

)

 

 

0.02

 

 

 

0.06

 

 

 

(4.86

)

Net income (loss)

 

$

(4.54

)

 

$

(6.09

)

 

$

2.29

 

 

$

1.50

 

 

$

(3.39

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares and equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

48,746

 

 

 

46,509

 

 

 

40,078

 

 

 

39,357

 

 

 

36,999

 

Diluted

 

 

49,217

 

 

 

47,103

 

 

 

43,073

 

 

 

42,547

 

 

 

38,075

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selected Balance Sheet Data:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total assets (4)

 

 

578,983

 

 

 

1,630,883

 

 

 

482,079

 

 

 

636,163

 

 

 

544,782

 

Long-term obligations (5)

 

 

470,744

 

 

 

1,079,528

 

 

 

30,589

 

 

 

 

 

 

164,297

 

 

 

(1)

In December 2020, we used the significant majority of the net proceeds from the divestiture of Nutrisystem to pay down $519.0 million of principal on the term loans under our Credit Agreement.  We allocated interest expense to discontinued operations for 2019 and 2020 based on the interest expense incurred from March 8, 2019 through December 8, 2020 based on such principal amount of $519.0 million and our historical interest rates.

 

22


(2)

The Tax Cuts and Jobs Act (the “Tax Act”), which was signed into law in December 2017, resulted in a reduction of the U.S. corporate income tax rate from 35% to 21% for tax years beginning after December 31, 2017.  In 2017, we incurred a non-cash charge to income tax expense of $7.4 million related to the Tax Act.  This charge related to both the re-measurement of our deferred tax assets to the lower tax rate and the requirement to recalculate the impact of repatriation of our foreign earnings, which occurred earlier in the year, under provisions of the new law. In addition, in 2017 we adopted Accounting Standards Update ("ASU") No. 2016-09, "Compensation-Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting" ("ASU 2016-09"), which requires the excess tax benefits from share-based awards to be recognized on a prospective basis in income tax expense, whereas they were previously recorded to stockholders’ equity.

 

(3)

Figures may not add due to rounding.

(4)

Includes assets of discontinued operation at December 31, 2019.  In addition, balances at December 31, 2020 and 2019 include right-of-use assets from continuing operations of $18.1 million and $25.6 million, respectively, due to the adoption of ASU No. 2016-02, “Leases”, on January 1, 2019. Prior period amounts were not adjusted and continue to be reported in accordance with our historical accounting policies.

(5)

Balances at December 31, 2020 and 2019 include long-term lease liabilities from continuing operations of $11.5 million and $19.6 million, respectively, due to the adoption of ASU No. 2016-02, “Leases”, on January 1, 2019. Balance at December 31, 2019 includes long-term lease liabilities of discontinued operation of $11.8 million.  Prior period amounts were not adjusted and continue to be reported in accordance with our historical accounting policies.

 

 

 

 

 

 

 

 

 

 

23


Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations

Please read the following discussion and analysis of our financial condition and results of operations together with our consolidated financial statements and related notes included under Item 8. "Financial Statements and Supplementary Data" of this report.

Overview

 

Tivity Health, Inc. (the “Company”), was founded and incorporated in Delaware in 1981.  Through our four programs, SilverSneakers® senior fitness, Prime® Fitness, WholeHealth LivingTM, and Wisely WellTM, we are focused on becoming the modern destination for healthy living, especially for seniors and older adults.   

 

We offer SilverSneakers to members of Medicare Advantage, Medicare Supplement, and group retiree plans.  We also offer Prime Fitness, a fitness facility access program, through commercial health plans, employers, and other sponsoring organizations.  Our national network of fitness centers delivers both SilverSneakers and Prime Fitness.  Our fitness networks encompass approximately 16,000 partner locations and nearly 1,000 alternative locations that provide classes outside of traditional fitness centers. We also offer virtual fitness experiences, including live instructor-led classes. Through our WholeHealth Living program, which we sell primarily to health plans, we offer a continuum of services related to complementary, alternative, and physical medicine.  Our WholeHealth Living network includes relationships with approximately 18,000 complementary, alternative, and physical medicine practitioner locations to serve individuals through health plans and employers who seek health services such as chiropractic care, acupuncture, physical therapy, occupational therapy, massage therapy, and more.  Finally, through our Wisely Well brand, we offer meals designed to support individuals and caregivers who are seeking meal convenience as well as those recovering after a hospitalization or living with chronic conditions.

Effective as of December 9, 2020, we completed the sale of Nutrisystem, Inc. (“Nutrisystem”), a wholly owned subsidiary of the Company that included the Nutrisystem® and South Beach Diet® programs, to KNS Acquisition Corp. (“Kainos”) pursuant to terms of a Stock Purchase Agreement (the “Purchase Agreement”), dated October 18, 2020, by and among the Company, Kainos, and Kainos NS Holdings LP.  At the closing (the “Closing”) of the transactions contemplated by the Purchase Agreement (the “Transactions”), Nutrisystem, Inc. and its subsidiaries were acquired by, and became wholly owned subsidiaries of, Kainos.  Pursuant to the terms of the Purchase Agreement, Kainos paid to the Company an aggregate purchase price, after giving effect to customary indebtedness and cash adjustments, of approximately $559 million, which amount is subject to a customary working capital adjustment post-Closing.  We used the significant majority of the net proceeds from the divestiture to pay down $519 million of principal on the term loans under our Credit Agreement.  Results of operations for Nutrisystem have been classified as discontinued operations for all periods presented in the consolidated financial statements, and all related assets and liabilities have been classified as discontinued operations at December 31, 2019.

The Company is headquartered at 701 Cool Springs Boulevard, Franklin, Tennessee 37067.

COVID-19

 

In January 2020, the Secretary of HHS declared a national public health emergency due to a novel strain of coronavirus, which causes the disease known as “COVID-19.”  In March 2020, the World Health Organization characterized the outbreak of COVID-19 as a global pandemic, and COVID-19 continues to spread throughout the United States and other countries.  Many state and local governments, together with public health officials, have recommended and mandated precautions to mitigate the spread of COVID-19, including ordering closure of certain businesses and imposing stay-at-home orders and social distancing guidelines for individuals. Such measures have resulted in significantly reduced demand for many businesses that have continued in operation.  

 

By March 31, 2020, substantially all of the fitness centers in our national network were temporarily closed, which had an adverse impact on our results from continuing operations for the first quarter of 2020 because a significant portion of revenues from our SilverSneakers program is based on member visits to a fitness partner location. A substantial number of our fitness partner locations remained closed through April, with some locations reopening in May and additional locations reopening in June and throughout the third quarter of 2020. Due to a resurgence of COVID-19 cases throughout the country, some fitness partner locations were closed again during the

24


fourth quarter of 2020.  For the month of December 2020, approximately 74% of our fitness partner locations reported at least one visit from our SilverSneakers program.  From April through December 2020, the average monthly total participation levels of our SilverSneakers members were significantly below historical levels, and we also experienced a decline in paid subscribers for Prime Fitness, each of which adversely impacted revenues from continuing operations.  We are unable to predict with certainty how many of our fitness partner locations will be subject to any operational restrictions in the future and for what duration, or the level of member participation at our fitness partner locations.  

Forward-Looking Statements

This report contains forward-looking statements, which are based upon current expectations, involve a number of risks and uncertainties, and are subject to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical statements of fact and those regarding the intent, belief, or expectations of the Company, including, without limitation, all statements regarding the Company's future earnings, revenues, and results of operations.  Readers are cautioned that any such forward-looking statements are not guarantees of future performance and involve significant risks and uncertainties, and that actual results may vary from those in the forward-looking statements as a result of various factors, including, but not limited to:

 

 

impacts from the COVID-19 pandemic (including the response of governmental authorities to combat and contain the pandemic, the closure of fitness centers in our national network (or operational restrictions imposed on such fitness centers), reclosures, and potential additional reclosures as a result of surges in positive COVID-19 cases) on our business, operations or liquidity;

 

 

the risks associated with changes in macroeconomic conditions (including the impacts of any recession or changes in consumer spending resulting from the COVID-19 pandemic), widespread epidemics, pandemics (such as the current COVID-19 pandemic) or other outbreaks of disease, geopolitical turmoil, and the continuing threat of domestic or international terrorism;

 

 

our ability to collect accounts receivable from our customers and amounts due under our sublease agreements;

 

 

the market’s acceptance of our new products and services;

 

 

our ability to develop and implement effective strategies and to anticipate and respond to strategic changes, opportunities, and emerging trends in our industry and/or business, as well as to accurately forecast the related impact on our revenues and earnings;

 

 

the impact of any impairment of our goodwill, intangible assets, or other long-term assets;

 

 

our ability to attract, hire, or retain key personnel or other qualified employees and to control labor costs;

 

 

the effectiveness of the reorganization of our business (including the 2020 COVID Restructuring Plan and the 2020 Healthcare Restructuring Plan, each as defined below) and our ability to realize the anticipated benefits;

 

 

our ability to effectively compete against other entities, whose financial, research, staff, and marketing resources may exceed our resources;

 

 

the impact of legal proceedings involving us and/or our subsidiaries, products, or services, including any claims related to intellectual property rights, as well as our ability to maintain insurance coverage with respect to such legal proceedings and claims on terms that would be favorable to us;

 

 

the impact of severe or adverse weather conditions, the current COVID-19 pandemic, and the potential emergence of additional health pandemics or infectious disease outbreaks on member participation in our programs;

 

25


 

the risks associated with deriving a significant concentration of our revenues from a limited number of our customers, many of whom are health plans;

 

 

our ability and/or the ability of our customers to enroll participants and to accurately forecast their level of enrollment and participation in our programs in a manner and within the timeframe we anticipate;

 

 

our ability to sign, renew and/or maintain contracts with our customers and/or our fitness partner locations under existing terms or to restructure these contracts on terms that would not have a material negative impact on our results of operations;

 

 

the ability of our health plan customers to maintain the number of covered lives enrolled in those health plans during the terms of our agreements;

 

 

our ability to add and/or retain paid subscribers in our Prime Fitness program;

 

 

the impact of a reduction in Medicare Advantage health plan reimbursement rates or changes in plan design;

 

 

the impact of any new or proposed legislation, regulations and interpretations relating to Medicare, Medicare Advantage, Medicare Supplement and privacy and security laws;

 

 

the impact of healthcare reform on our business;

 

 

the risks associated with potential failures of our information systems or those of our third-party vendors, including as a result of telecommuting issues associated with personnel working remotely, which may include a failure to execute on policies and processes in a work-from-home or remote model;

 

 

the risks associated with data privacy or security breaches, computer hacking, network penetration and other illegal intrusions of our information systems or those of third-party vendors or other service providers, including those risks that result from the increase in personnel working remotely, which may result in unauthorized access by third parties, loss, misappropriation, disclosure or corruption of customer, employee or our information, or other data subject to privacy laws and may lead to a disruption in our business, costs to modify, enhance, or remediate our cybersecurity measures, enforcement actions, fines or litigation against us, or damage to our business reputation;

 

 

the risks associated with changes to traditional office-centered business processes and/or conducting operations out of the office in a work-from-home or remote model by us or our third-party vendors during adverse situations (e.g., during a crisis, disaster, or pandemic), which may result in additional costs and/or may negatively impact productivity and cause other disruptions to our business;

 

 

our ability to enforce our intellectual property rights;

 

 

the risk that our indebtedness may limit our ability to adapt to changes in the economy or market conditions, expose us to interest rate risk for the variable rate indebtedness and require a substantial portion of cash flows from operations to be dedicated to the payment of indebtedness;

 

 

our ability to service our debt, make principal and interest payments as those payments become due, and remain in compliance with our debt covenants;

 

 

our ability to obtain adequate financing to provide the capital that may be necessary to support our current or future operations;

 

 

counterparty risk associated with our interest rate swap agreements; and

 

other risks detailed in this report and our other filings with the Securities and Exchange Commission.

We undertake no obligation to update or revise any such forward-looking statements.

26


Critical Accounting Policies

We describe our significant accounting policies in Note 1 of the notes to the consolidated financial statements.  We prepare the consolidated financial statements in conformity with generally accepted accounting principles in the United States (“U.S. GAAP”), which requires us to make estimates and judgments that affect the reported amounts of assets and liabilities and related disclosures at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates.

We believe the following accounting policies are the most critical in understanding the estimates and judgments that are involved in preparing our financial statements and the uncertainties that could impact our results of operations, financial condition, and cash flows.

Revenue Recognition

 

Beginning in 2018, we account for revenue from contracts with customers in accordance with Accounting Standards Codification (“ASC”) Topic 606 “Revenue from Contracts with Customers” (“ASC Topic 606”).  The unit of account in ASC Topic 606 is a performance obligation, which is a promise in a contract to transfer to a customer either a distinct good or service (or bundle of goods or services) or a series of distinct goods or services provided over a period of time. ASC Topic 606 requires that a contract’s transaction price, which is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods or services to a customer, is to be allocated to each performance obligation in the contract based on relative standalone selling prices and recognized as revenue when or as the performance obligation is satisfied.

 

We earn revenue from continuing operations primarily from three programs: SilverSneakers senior fitness, Prime Fitness and WholeHealth Living.  We provide the SilverSneakers senior fitness program to members of Medicare Advantage and Medicare Supplement plans through our contracts with those plans.  We offer Prime Fitness, a fitness facility access program, through contracts with commercial health plans, employers, and other sponsoring organizations that allow their members to individually purchase the program.  We sell our WholeHealth Living program primarily to health plans.

 

The significant majority of our customer contracts contain one performance obligation - to stand ready to provide access to our network of fitness locations and fitness programming - which is satisfied over time as services are rendered each month over the contract term.  There are generally no performance obligations that are unsatisfied at the end of a particular month.  There was no material revenue recognized during the year ended December 31, 2020 from performance obligations satisfied in a prior period.  

 

Our fees are variable month to month and are generally billed per member per month (“PMPM”) or billed based on a combination of PMPM and member visits to a network location.  We bill PMPM fees by multiplying the contractually negotiated PMPM rate by the number of members eligible for or receiving our services during the month.  We bill for member visits approximately one month in arrears once actual member visits are known.  Payments from customers are typically due within 30 days of invoice date.  When material, we capitalize costs to obtain contracts with customers and amortize them over the expected recovery period.  

 

Our customer contracts include variable consideration, which is allocated to each distinct month over the contract term based on eligible members and/or member visits each month.  The allocated consideration corresponds directly with the value to our customers of our services completed for the month.  Under the majority of our contracts, we recognize revenue each month using the practical expedient available under ASC 606-10-55-18, which provides that revenue is recognized in the amount for which we have the right to invoice.  ASC 606-10-50-14(b) provides an optional exemption, which we have elected to apply, from disclosing remaining performance obligations when revenue is recognized from the satisfaction of the performance obligation in accordance with the “right to invoice” practical expedient.

 

Although we evaluate our financial performance and make resource allocation decisions based upon the results of our single operating and reportable segment, we believe the following information depicts how our revenues and cash flows from continuing operations are affected by economic factors.  For the year ended December 31, 2020, revenue from our SilverSneakers program, which is predominantly contracted with Medicare Advantage and Medicare Supplement plans, comprised 72% of revenues from continuing operations, while revenue from our Prime

27


Fitness and WholeHealth Living programs comprised 22% and 5%, respectively, of revenues from continuing operations.

 

Sales and usage-based taxes are excluded from revenues.

Impairment of Intangible Assets and Goodwill

 

We review goodwill for impairment at the reporting unit level (operating segment or one level below an operating segment) on an annual basis (during the fourth quarter of our fiscal year) or more frequently whenever events or circumstances indicate that the carrying value may not be recoverable.  Following the sale of Nutrisystem in December 2020, we have a single reporting unit.

 

As part of the annual impairment test, we may elect to perform a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. If we elect not to perform a qualitative assessment or we determine that it is more likely than not that the fair value of the reporting unit is less than its carrying value, we perform a quantitative review as described below.

 

During a quantitative review of goodwill, we estimate the fair value of the reporting unit based on a discounted cash flow model or a combination of a discounted cash flow model and market-based approaches, and we reconcile the fair value of the reporting unit to our consolidated market capitalization.  If the fair value of the reporting unit exceeds its carrying amount, no impairment is indicated. If the fair value of the reporting unit is less than its carrying amount, impairment of goodwill is measured as the excess of the carrying amount over fair value.  Estimating fair value requires significant judgments, including management's estimate of future cash flows of the reporting unit (which is dependent on internal forecasts of projected income), estimation of the long-term growth rates of future revenues for the reporting unit, the terminal growth rate of revenue, the tax rate, and determination of the weighted average cost of capital, as well as relevant comparable company revenue and earnings multiples and market participant acquisition premium for the market-based approaches.  Changes in these estimates and assumptions could materially affect the estimate of fair value and potential goodwill impairment for the reporting unit.

 

Except for a tradename that has an indefinite life and is not subject to amortization, we amortize identifiable intangible assets over their estimated useful lives on a straight-line or accelerated basis based on the period for which the economic benefits of the asset are expected to be realized. We assess the potential impairment of intangible assets subject to amortization whenever events or changes in circumstances indicate that the carrying values may not be recoverable. If we determine that the carrying value of other identifiable intangible assets may not be recoverable, we calculate any impairment using an estimate of thasset's fair value based on the estimated price that would be received to sell the asset in an orderly transaction between market participants.  

 

We review indefinite-lived intangible assets for impairment on an annual basis (during the fourth quarter of our fiscal year) or more frequently whenever events or circumstances indicate that the carrying value may not be recoverable. We estimate the fair value of our indefinite-lived tradename using the relief-from-royalty method, which requires us to estimate significant assumptions such as the long-term growth rates of future revenues associated with the tradename, the royalty rate for such revenue, the terminal growth rate of revenue, the tax rate, and a discount rate.  Changes in these estimates and assumptions could materially affect the estimates of fair value for the tradename.

Key Performance Indicators

 

In managing our business, we regularly review and analyze a number of key performance indicators (“KPIs”), including revenues, adjusted EBITDA (both in dollars and as a percentage of revenues), and free cash flow.  Adjusted EBITDA and free cash flow are not calculated in accordance with U.S. GAAP (“non-GAAP”).  These KPIs help us monitor our performance, identify trends affecting our business, determine the allocation of resources, and assess the quality and potential variability of our cash flows and earnings.  We believe they are useful to investors in evaluating and understanding our business.

 

Following the divestiture of Nutrisystem, we have only one reportable segment and therefore no longer review and analyze revenues on a segment-level basis or adjusted EBITDA on a segment-level basis as KPIs. Instead, we

28


review and analyze revenues from continuing operations and adjusted EBITDA from continuing operations. Additionally, beginning in 2020, we have revised the definition of free cash flow to exclude settlement on derivatives not designated as hedges, a new item for 2020 that did not exist in prior periods. Settlement on derivatives not designated as hedges arose in 2020 due to the de-designation of certain interest rate swaps in the fourth quarter of 2020 in connection with the repayment of a portion of the principal on the term loans under our Credit Agreement, as further described in Note 13 of the notes to consolidated financial statements included in this report. We believe it is appropriate to exclude settlement on derivatives not designated as hedges from free cash flow because these payments are similar to interest payments (which are reflected in cash flow from operating activities) and they reduce our cash available to repay debt or make other investments.

 

 

 

Year Ended December 31,

 

(In $000s)

 

2020

 

 

2019

 

 

2018

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenues from continuing operations

 

$

437,714

 

 

$

633,066

 

 

$

606,299

 

Adjusted EBITDA from continuing operations

 

 

147,855

 

 

 

142,561

 

 

 

142,168

 

Adjusted EBITDA as a percentage of

   revenues from continuing operations

 

 

33.8

%

 

 

22.5

%

 

 

23.4

%

 

 

Revenues – we review year-over-year changes in revenue from continuing operations as a key measure of our success in growing our business.  In addition to measuring revenue in total, we also measure and report revenue by program type or source of revenue, as detailed in Note 4 of the notes to the consolidated financial statements included in this report, i.e., SilverSneakers, Prime Fitness, WholeHealth Living, and Other.  Evaluating revenue by program type or source helps us identify and address changes in product mix, broad market factors that may affect our revenues, and opportunities for future growth.

 

 

Adjusted EBITDA is a non-GAAP measure and is defined by the Company as earnings before interest, taxes, depreciation and amortization, acquisition, integration, and project costs, CEO transition costs, and restructuring charges.  We believe adjusted EBITDA provides investors a helpful measure for comparing our operating performance with our historical operating results as well as the performance of other companies that may have different financing and capital structures or tax rates. We believe it is a useful indicator of the operational strength and performance of our business.  Because adjusted EBITDA may be defined differently by other companies in our industry, the financial measure presented herein may not be comparable to similarly titled measures of other companies.  A reconciliation of adjusted EBITDA to net income (the most comparable U.S. GAAP measure) is set forth below.

 

 

 

Year Ended December 31,

 

(In thousands)

 

2020

 

 

2019

 

 

2018

 

Income from continuing operations, GAAP basis

 

$

56,869

 

 

$

45,217

 

 

$

97,902

 

Income tax expense

 

 

17,530

 

 

 

20,293

 

 

 

27,046

 

Interest expense

 

 

43,477

 

 

 

41,803

 

 

 

8,733

 

Depreciation expense

 

 

9,930

 

 

 

7,137

 

 

 

4,667

 

EBITDA, non-GAAP basis (1)

 

$

127,806

 

 

$

114,450

 

 

$

138,348

 

Acquisition, integration, project and CEO transition costs (2)

 

 

15,691

 

 

 

26,230

 

 

 

3,696

 

Restructuring charges (3)

 

 

4,358

 

 

 

1,881

 

 

 

124

 

Adjusted EBITDA, non-GAAP basis (4)

 

$

147,855

 

 

$

142,561

 

 

$

142,168

 

29


 

 

(1)

EBITDA is a non-GAAP financial measure.  We believe it is useful to investors to provide disclosures of our operating results on the same basis as that used by management.  You should not consider EBITDA in isolation or as a substitute for income from continuing operations determined in accordance with U.S. GAAP.

 

(2)

Acquisition, integration, project and CEO transition costs consist of pre-tax charges of $15,691, $26,230, and $3,696 for fiscal 2020, 2019, and 2018, respectively, incurred in connection with the acquisition and integration of Nutrisystem and other strategic projects and with the termination of our former CEO in February 2020 and the hiring of our new CEO in June 2020.

 

(3)

Restructuring charges in 2020 consist of pre-tax charges of $4,358 related to the 2020 COVID Restructuring Plan and the 2020 Restructuring Plan (each as further defined below).  Restructuring charges for 2019 consist of pre-tax charges of $1,881 related to the 2019 Restructuring Plan (as defined below).  Restructuring charges for 2018 consist of pre-tax charges of $124 primarily due to additional costs related to a prior restructuring.

 

(4)

Adjusted EBITDA is a non-GAAP financial measure.  We exclude acquisition, integration, project and CEO transition costs and restructuring charges from this measure because of its comparability to our historical operating results. We believe it is useful to investors to provide disclosures of our operating results on the same basis as that used by management.  You should not consider Adjusted EBITDA in isolation or as a substitute for income from continuing operations determined in accordance with U.S. GAAP.  Additionally, because Adjusted EBITDA may be defined differently by other companies in the Company’s industry, the non-GAAP financial measure presented here may not be comparable to similarly titled measures of other companies.

 

 

Free cash flow is a non-GAAP measure and is defined by the Company as net cash flows provided by operating activities less acquisition of property and equipment and settlement on derivatives not designated as hedges.  We believe free cash flow is useful to management and investors to measure (i) our performance, (ii) the strength of the Company and its ability to generate cash, and (iii) the amount of cash that is available to repay debt or make other investments.  A reconciliation of free cash flow to cash flows from operating activities (the most comparable U.S. GAAP measure) is set forth below.  The amounts shown below represent consolidated figures that include the effects of owning Nutrisystem.

 

 

 

Year Ended December 31,

 

(In thousands)

 

2020

 

 

2019

 

 

2018

 

Net cash flows provided by operating activities

 

$

169,447

 

 

$

82,305

 

 

$

108,739

 

Acquisition of property and equipment

 

 

(15,525

)

 

 

(24,713

)

 

 

(9,053

)

Settlement on derivatives not designated as hedges

 

 

(1,499

)

 

 

 

 

 

 

Free cash flow

 

$

152,423

 

 

$

57,592

 

 

$

99,686

 

Outlook

Although there is significant uncertainty relating to the potential impacts of the COVID-19 pandemic on our business going forward, including the duration of the outbreak, the timing and duration of any operational restrictions applicable to our fitness partner locations, the impact on member participation in our SilverSneakers programs, our ability to continue to attract paying subscribers for our Prime Fitness program, and the ultimate medium- and long-term impact of the pandemic on the global economy, we expect our results from continuing operations for the short term to continue to be adversely impacted by COVID-19.

Executive Overview of Results

The key financial results for the year ended December 31, 2020 are:

 

Revenues of $437.7 million for the year ended December 31, 2020 compared to $633.1 million for the year ended December 31, 2019; and

 

Pre-tax income from continuing operations of $74.4 million for the year ended December 31, 2020 compared to $65.5 million for the year ended December 31, 2019. Pre-tax income from continuing operations for 2020 includes:

30


 

o

$43.5 million of interest expense compared to $41.8 million for 2019;

 

o

$12.2 million of marketing expenses, compared to $17.7 million for 2019;

 

o

$6.6 million of CEO transition costs compared to $0 for 2019;

 

o

$5.7 million of transition, acquisition, and integration costs compared to $26.2 million for 2019;

 

o

$4.4 million of restructuring and related charges compared to $1.9 million for 2019;

 

o

$3.4 million of strategic project costs compared to $0 for 2019.

 

Loss from discontinued operations, net of income tax benefit, of $280.5 million for the year ended December 31, 2020 compared to $332.0 million for the year ended December 31, 2019.

Results of Operations

The following table sets forth the components of the consolidated statements of operations for the years ended December 31, 2020, 2019, and 2018 expressed as a percentage of revenues from continuing operations.  

 

&